<SEC-DOCUMENT>0001558370-22-008267.txt : 20220511
<SEC-HEADER>0001558370-22-008267.hdr.sgml : 20220511
<ACCEPTANCE-DATETIME>20220511112441
ACCESSION NUMBER:		0001558370-22-008267
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20220511
FILED AS OF DATE:		20220511
DATE AS OF CHANGE:		20220511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		22912628

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tmb-20220511x6k.htm
<DESCRIPTION>6-K
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 5/11/2022 03:19:09 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Washington,&#160;D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">FORM&#160;6-K</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">FOR THE&#160;MONTH OF MAY 2022</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;white-space:pre-wrap;">COMMISSION FILE NUMBER 001-38976  </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">Genmab A/S</b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><br></b><font style="color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;background:#ffffff;">(Exact name of Registrant as specified in its charter)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Kalvebod Brygge 43</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">1560 Copenhagen V</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Denmark</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;">+45 70 20 27 28</b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;"><br></b><font style="color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;background:#ffffff;">(Address of principal executive offices)</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Form&#160;20-F&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      Form&#160;40-F&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(1)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(7)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="background:#ffffff;">Exhibit 99.1 to this report on Form&#160;6-K&#160;shall be deemed to be&#160;</font>incorporated by reference<font style="background:#ffffff;">&#160;in Genmab A/S&#8217;s registration statement on&#160;</font><font style="background:#ffffff;">Form&#160;S-8</font><font style="background:#ffffff;">&#160;(File&#160;No.&#160;333-232693)&#160;and in the outstanding prospectus contained in such registration statement. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">SIGNATURE</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">GENMAB A/S</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">BY:</font></p></td><td style="vertical-align:bottom;width:45.3%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">/s/ Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Name: Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Title: Executive Vice President &amp; Chief Financial Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">DATE: May 11, 2022</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">EXHIBIT&#160;INDEX</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:96.42%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">A</b></p></div></div></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit</u></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Description of Exhibit</u></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr style="height:11.8pt;"><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">99.1</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Interim Report Dated May 11, 2022 &#160;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tmb-20220511xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 5/11/2022 03:19:21 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title>Interim Report for the 6 months ended June 30, 2011</title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt;"><a name="_Hlk102650841"></a><b style="color:#029c93;font-weight:bold;">May 11, 2022 Copenhagen, Denmark; </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interim Report for the First Quarter Ended March 31, 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Highlights</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">DARZALEX</b><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:bold;vertical-align:top;">&#174;</sup><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;"> net sales as reported by Johnson &amp; Johnson increased 36% compared to the first three months of 2021 to USD 1,856 million, resulting in royalty revenue of DKK 1,501 million</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Genmab updates its 2022 financial guidance</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk12956096"></a>&#8220;During the first quarter of 2022, there were continued advancements in our pipeline, including the first patient dosed with DuoBody<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup>-CD3xB7H4 (GEN1047), the presentation of data from the tisotumab vedotin innovaTV 207 study, and the U.S. Food and Drug Administration (U.S. FDA) granting orphan-drug designation to epcoritamab for the treatment of follicular lymphoma (FL). Together these events help to progress us further in our evolution into a fully integrated biotech innovation powerhouse,&#8221; said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;">Financial Performance First Quarter of 2022</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Net sales of DARZALEX by Janssen were USD 1,856 million in the first three months of 2022 compared to USD 1,365 million in the first three months of 2021, an increase of USD 491 million, or 36%.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Royalty revenue was DKK 1,836 million in the first three months of 2022 compared to DKK 1,017 million in the first three months of 2021, an increase of DKK 819 million, or 81%. The increase was driven by higher net sales of DARZALEX, TEPEZZA</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> and Kesimpta</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> resulting in higher royalties.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Revenue was DKK 2,119 million for the first three months of 2022 compared to DKK 1,581 million for the first three months of 2021. The increase of DKK 538 million, or 34%, was primarily driven by higher DARZALEX, TEPEZZA and Kesimpta royalties achieved under our collaborations with Janssen, Roche and Novartis, respectively, partly offset by milestones achieved under our collaborations with AbbVie and Janssen in the first three months of 2021.</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_Hlk527456255"></a></font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="_Hlk527456303"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Operating expenses were DKK 1,605 million in the first three months of 2022 compared to DKK 1,049 million in the first three months of 2021. The increase of DKK 556 million, or 53%, was driven by the continued advancement of multiple pipeline projects, the increase in </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">new employees to support Tivdak</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> post launch and </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">expansion of our product pipeline</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">, as well as the continued development of commercialization capabilities and Genmab&#8217;s broader organizational infrastructure.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"><a name="OLE_LINK13"></a><a name="OLE_LINK14"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Operating profit was DKK 514 million in the first three months of 2022 compared to DKK 532 million in the first three months of 2021. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Subsequent Events</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">April: Genmab and AbbVie Inc. (AbbVie) announced topline results for epcoritamab from the first cohort of the EPCORE&#8482; NHL-1 phase 1/2 clinical trial evaluating epcoritamab. The study cohort includes 157 patients with relapsed / refractory large B-cell lymphoma who received at least two prior lines of systemic therapy, including 38.9% who received prior treatment with chimeric antigen receptor T-cell therapy. The topline results from this cohort demonstrated an overall response rate of 63.1% as confirmed by an independent review committee, which exceeded the protocol prespecified threshold for efficacy. The observed median duration of response was 12 months. The most common treatment-emergent adverse event was cytokine release syndrome </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 1/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">with 49.7%, including 2.5% grade 3. Based on the topline results, the companies will engage global regulatory authorities to determine next steps.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">April: The arbitral tribunal issued an award in the binding arbitration of two matters arising under Genmab&#8217;s license agreement with Janssen relating to daratumumab. Genmab did not seek a review of the award, and the award is now final. The arbitral tribunal decided both issues in favor of Janssen. The first issue concerned the question as to whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement.  As to that issue, the tribunal determined by majority opinion that Janssen&#8217;s obligation to pay royalties to Genmab on sales of licensed product, in each applicable country, extends through the expiration or invalidation of the last-to-expire relevant Genmab-owned patent covering the product or use thereof, but not the relevant Janssen-owned patent. The relevant Genmab-owned issued U.S., European and Japanese patents will expire in the late 2020s and early 2030s. The second issue concerned the question as to whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme Therapeutics, Inc. (Halozyme) for the Halozyme enzyme technology used in the subcutaneous (SC) formulation of daratumumab (marketed as DARZALEX FASPRO</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> in the U.S.).</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of SC daratumumab sales. As to that issue, the tribunal ruled by majority opinion that Janssen is permitted to continue reducing its royalty payments to Genmab as an offset against a share of Janssen&#8217;s royalty payments made to Halozyme. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is updating the lower end of its 2022 financial guidance published on February 16, 2022, driven by increased royalty revenue related to net sales of DARZALEX.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">11,000 - 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">10,800 - 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(7,200) - (7,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(7,200) - (7,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3,200 - 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3,000 - 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Conference Call</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab will hold a conference call in English to discuss the results for the first quarter of 2022 today, Wednesday, May 11, at 6:00 pm CEST, 5:00 pm BST or 12:00 pm EDT. To join the call dial </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK3"></a><a name="OLE_LINK4"></a>+1 631 913 1422 (U.S. participants) or +44 3333000804 (international participants) and provide conference code 48414786. A live and archived webcast of the call and relevant slides will be available at www.genmab.com/investors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Contact:</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marisol Peron, Senior Vice President, Communications and Corporate Affairs</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +1 609 524 0065; E: mmp@genmab.com</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Andrew Carlsen, Vice President, Head of Investor Relations</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +45 3377 9558; E: acn@genmab.com</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 2/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONTENTS</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><b style="color:#029c93;font-weight:bold;">MANAGEMENT&#8217;S REVIEW</b></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#CONSOLIDATEDKEYFIGURES_439617"><font style="font-style:normal;font-weight:normal;">CONSOLIDATED KEY FIGURES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#OUTLOOK_182548"><font style="font-style:normal;font-weight:normal;">OUTLOOK</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">5</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#KEY2019PRIORITIES_328557"><font style="font-style:normal;font-weight:normal;">KEY 2022 PRIORITIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#PRODUCTPIPELINE_603298"><font style="font-style:normal;font-weight:normal;">PRODUCT PIPELINE</font></a> <a href="#PRODUCTPIPELINE_603298"><font style="font-style:normal;font-weight:normal;">AND TECHNOLOGY PROGRESS FIRST QUARTER OF 2022 </font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#_SIGNIFICANT_RISKS_AND"><font style="font-style:normal;font-weight:normal;">SIGNIFICANT RISKS AND UNCERTAINTIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">14</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#FINANCIALREVIEW_601130"><font style="font-style:normal;font-weight:normal;">FINANCIAL REVIEW</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">15</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><b style="color:#029c93;font-weight:bold;">FINANCIAL STATEMENTS</b></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#Statementsofcomprehensiveincome"><font style="font-style:normal;font-weight:normal;">STATEMENTS OF COMPREHENSIVE INCOME FOR THE FIRST QUARTER OF 2022</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">21</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#BALANCESHEET_757698"><font style="font-style:normal;font-weight:normal;">BALANCE SHEETS AS OF MARCH 31, 2022</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">22</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCASHFLOWS_489627"><font style="font-style:normal;font-weight:normal;">STATEMENTS OF CASH FLOWS FOR THE FIRST QUARTER OF 2022</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">23</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCHANGESINEQUITY_43137"><font style="font-style:normal;font-weight:normal;">STATEMENTS OF CHANGES IN EQUITY FOR THE FIRST QUARTER OF 2022</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">24</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#NOTESTOTHEFINANCIALSTATEMENTS_435403"><font style="font-style:normal;font-weight:normal;">NOTES&#160;TO THE FINANCIAL STATEMENTS</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">25</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#ABOUTGENMAB_556806"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">ABOUT GENMAB</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">33</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;" href="#DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">34</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 3/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">CONSOLIDATED KEY FIGURES</b><b style="font-size:16pt;font-weight:bold;"><a name="_MON_1428392831"></a></b><b style="color:#339966;font-weight:bold;white-space:pre-wrap;">   </b><b style="font-size:16pt;font-weight:bold;"><a name="CONSOLIDATEDKEYFIGURES_439617"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.07%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">Full Year</p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">March 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.07%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,119</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,581</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,482</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,153)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (848)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (4,181)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (452)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (201)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,283)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,605)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,049)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (5,464)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 514</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 532</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,018</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net financial items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 98</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 965</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 465</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,008</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,917</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,191</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,381</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,071</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,957</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,739</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,273</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,891</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 24,914</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,210</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 24,627</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,719</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20,095</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,196</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Cash Flow Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 587</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,228</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (667)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (579)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (961)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (64)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (220)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (420)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (57)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (28)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (252)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Financial Ratios</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Basic net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.10</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.76</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 46.00</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Diluted net profit per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.05</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.61</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 45.54</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Period-end share market price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,465</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,087</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,630</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Price / book value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6.85</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.82</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 344.23</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 304.47</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 336.30</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Equity ratio</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 91</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,734,141</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,587,322</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,718,456</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Average number of employees (FTE*)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,285</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 842</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,022</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Number of employees (FTE) at the end of the period </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.89%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,309</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 871</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.75%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,212</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><font style="white-space:pre-wrap;">* Full-time equivalent or team members  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 4/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk101868056_0"></a><a name="_Toc16514641"></a><b style="font-size:11pt;font-weight:bold;">OUTLOOK</b><b style="font-size:11pt;font-weight:bold;"> </b><a name="OUTLOOK_182548"></a><a name="_Hlk22722517"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">11,000 - 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">10,800 - 12,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(7,200) - (7,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(7,200) - (7,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3,200 - 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3,000 - 4,800</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is updating the lower end of its 2022 financial guidance published on February 16, 2022, driven by increased royalty revenue related to net sales of DARZALEX.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab expects its 2022 revenue to be in the range of DKK 11,000 &#8211; 12,000 million, an increase to the lower end of the previous guidance of DKK 10,800 &#8211; 12,000 million, driven primarily by the continued strong growth of DARZALEX net sales. Genmab&#8217;s projected revenue for 2022 primarily consists of DARZALEX royalties of DKK 8,000 &#8211; 8,500 million compared to previous guidance of DKK 7,700 &#8211; 8,500. Such royalties are based on Genmab&#8217;s revised estimate of DARZALEX 2022 net sales of USD 7.5 &#8211; 8.0 billion compared to previous guidance of USD 7.3 &#8211; 8.0 billion. DARZALEX royalties are partly offset by the impact of Janssen&#8217;s withholding of a portion of royalty payments related to Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with SC sales. The remainder of Genmab&#8217;s revenue consists of royalties from TEPEZZA, Kesimpta and RYBREVANT<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup>, reimbursement revenue, milestones for epcoritamab, teclistamab and other milestones as well as collaboration revenue with Seagen for Tivdak.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab anticipates its 2022 operating expenses to continue to be in the range of DKK 7,200 &#8211; 7,800 million. Operating expenses continue to be driven by the advancement of Genmab&#8217;s clinical programs, continued investment in research and development, as well as building Genmab&#8217;s commercial organization and broader organizational infrastructure. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Profit</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab now expects its 2022 operating result to be in the range of DKK 3,200 &#8211; 4,800 million, an increase to the lower end of the previous guidance of DKK 3,000 &#8211; 4,800 million, driven primarily by the increase in royalty revenue related to the net sales of DARZALEX.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook: Risks and Assumptions</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to factors already mentioned, the estimates above are subject to change due to numerous reasons, including but not limited to, the achievement of certain milestones associated with Genmab&#8217;s collaboration agreements; the timing and variation of development activities (including activities carried out by Genmab&#8217;s collaboration partners) and related income and costs; DARZALEX, Kesimpta, TEPEZZA and RYBREVANT net sales and royalties paid to Genmab; and currency exchange rates (the 2022 guidance assumes a USD / DKK exchange rate of 6.4). The financial guidance assumes that no significant new agreements are entered into during the remainder of 2022 that could materially affect the results. Refer to the section &#8220;Significant Risks and Uncertainties&#8221; in this interim report. Additionally, depending on trends related to the coronavirus and future variants, the COVID-19 pandemic could potentially have a material adverse impact on Genmab&#8217;s business and financial performance, including clinical trials, projected regulatory approval timelines, supply chain and revenues, and cause Genmab&#8217;s actual results to differ materially from 2022 Guidance and Key 2022 Priorities in this interim report. </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 5/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffff00;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Should the global outbreak of COVID-19 persist, it may have long-term impacts on the development, regulatory approval and commercialization of Genmab&#8217;s investigational medicines and on net sales of approved medicines created by Genmab and developed and marketed by Genmab or Genmab&#8217;s collaboration partners. As the pandemic continues, there may be an impact on Genmab&#8217;s business. Genmab has an established COVID-19 response team, led by the CEO, that closely monitors the evolving situation, maintains precautionary measures to help limit the impact of COVID-19 at the workplace and on our communities, and ensures business continuity. The full extent and nature of the impact of the COVID-19 pandemic and related containment measures on Genmab&#8217;s business and financial performance is uncertain as the situation continues. The factors discussed above, as well as other factors that are currently unforeseeable, may result in further and other unforeseen material adverse impacts on Genmab&#8217;s business and financial performance, including on the sales of Tivdak and on net sales of DARZALEX, Kesimpta, TEPEZZA and RYBREVANT by Genmab&#8217;s partners and on Genmab&#8217;s royalty and milestone revenue therefrom.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514642"></a></b><b style="color:#029c93;font-weight:bold;">KEY 2022 PRIORITIES</b><b style="font-size:16pt;font-weight:bold;"><a name="KEY2019PRIORITIES_328557"></a></b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:99.89%;"><tr style="height:1pt;"><td style="vertical-align:top;width:29.83%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:4.81%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:65.34%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:29.83%;background:#029c93;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#ffffff;font-weight:bold;">Priority</b></p></td><td style="vertical-align:top;width:4.81%;background:#029c93;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="color:#ffffff;font-family:'Times New Roman';font-weight:bold;">&#10003;</b></p></td><td style="vertical-align:top;width:65.34%;background:#029c93;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#ffffff;font-weight:bold;">Targeted Milestones</b></p></td></tr><tr style="height:52.6pt;"><td style="vertical-align:top;width:29.83%;border-left:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Broad and rapid development of late-stage clinical pipeline and further build US country organization</p></td><td style="vertical-align:top;width:4.81%;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Epcoritamab</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">1</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Expand clinical development program with multiple Phase 3 trials initiated and submission&#160;of first BLA (subject to supportive FDA feedback)</font></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:3pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:29.83%;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.81%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-bottom:1px solid #b9fefa;border-right:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Tivdak</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">2</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="color:#029c93;display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Establish Tivdak as a clear choice for 2L+ r/m Cervical Cancer patients</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="color:#029c93;display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Broaden clinical development program including Phase 2 evaluation of combination therapy in&#160;earlier line treatment for cervical cancer and other solid tumors</font></div></div></div></td></tr><tr><td style="vertical-align:top;width:29.83%;border-left:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Growth and development of differentiated early-stage product candidates</p></td><td style="vertical-align:top;width:4.81%;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">DuoBody-PD-L1x4-1BB</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">3</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> &amp; DuoBody-CD40x4-1BB</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">3</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">&#160;</font></div></div></div><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="width:18pt;display:table-cell;"></div><div style="color:#029c93;display:table-cell;font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Data from clinical expansion cohorts to progress to next steps</font></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:3pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:3pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:3pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:29.83%;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.81%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-bottom:1px solid #b9fefa;border-right:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Expand and advance proprietary clinical product portfolio</font></div></div></div></td></tr><tr><td style="vertical-align:top;width:29.83%;border-left:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Further scale organization aligned with growing product portfolio and brand needs</p></td><td style="vertical-align:top;width:4.81%;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-right:1px solid #b9fefa;border-top:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Further scale organization aligned with differentiated antibody product portfolio growth and future launches</font></div></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:3pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:29.83%;border-bottom:1px solid #b9fefa;border-left:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.15pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:4.81%;border-bottom:1px solid #b9fefa;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.34%;border-bottom:1px solid #b9fefa;border-right:1px solid #b9fefa;margin:0pt;padding:0pt 5.15pt 0pt 5.4pt;"><div border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;display:table;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><div style="display:table-row;"><div style="color:#029c93;display:table-cell;font-family:'Wingdings';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#216;</div><div style="display:table-cell;padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Use solid financial base to grow and broaden antibody product and technology portfolio</font></div></div></div></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1.&#160;Co-development w/ AbbVie; 2. Co-development w/ Seagen Inc. (Seagen); 3. Co-development w/ BioNTech SE (BioNTech)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">PRODUCT PIPELINE</b><a name="PRODUCTPIPELINE_603298"></a><b style="color:#029c93;font-weight:bold;"> AND TECHNOLOGY PROGRESS FIRST QUARTER OF 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">At the end of the first quarter of 2022, Genmab&#8217;s proprietary pipeline of investigational medicines, where we are responsible for at least 50% of development, consisted of seven antibody products in clinical development. These include Genmab&#8217;s first U.S. FDA approved medicine, Tivdak, which Genmab is co-developing and co-promoting in the U.S. with Seagen. In addition to our own pipeline, there are multiple investigational medicines in development by global pharmaceutical and biotechnology companies, including four approved medicines powered by Genmab&#8217;s technology and innovations. Beyond the </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 6/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">investigational medicines in clinical development, our pipeline also includes multiple preclinical programs. An overview of the development status of each of our investigational medicines is provided in the following sections. Detailed descriptions of dosing, efficacy and safety data from certain clinical trials have been disclosed in company announcements and media releases published via the Nasdaq Copenhagen stock exchange and may also be found in Genmab&#8217;s filings with the U.S. Securities and Exchange Commission (SEC). Additional information is available on Genmab&#8217;s website, www.genmab.com. The information accessible through our website is not part of and is not incorporated by reference herein.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="PRODUCTPIPELINEANDTECHNOLOGYPROGRESSFIRS"></a><font style="color:#339966;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Genmab Proprietary Investigational Medicines</b><sup style="color:#029c93;font-size:8.25pt;font-weight:bold;vertical-align:top;">1 </sup><b style="color:#029c93;font-size:11pt;font-weight:bold;">in Development</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><img src="tmb-20220511xex99d1005.jpg" alt="Table&#10;&#10;Description automatically generated" style="display:inline-block;height:241.85pt;width:468pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 0pt 0pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup>Investigational medicines where Genmab has &#8805;50% ownership. Certain investigational medicines in co-development, partners as indicated</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:18pt;margin:0pt 36pt 0pt -18pt;"><sup style="font-size:6pt;vertical-align:top;">2</sup>See U.S. prescribing information for precise indication and safety information</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:18pt;margin:0pt 36pt 0pt -18pt;"><sup style="font-size:6pt;vertical-align:top;">3</sup>Genmab is developing HexaBody-CD38 in an exclusive worldwide license and option agreement with Janssen</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 0pt 0pt;"><font style="font-size:8pt;margin-bottom:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Tivdak (tisotumab vedotin-tftv) &#8211; First and only U.S. FDA approved antibody-drug conjugate (ADC) for recurrent or metastatic cervical cancer</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">An ADC directed to tissue factor (TF), a protein highly prevalent in solid tumors, including cervical cancer, which is associated with poor prognosis</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Accelerated approval granted by the U.S. FDA for </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Tivdak</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">, the first and only approved ADC for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">U.S. FDA approval was based on data from the innovaTV 204 (NCT03438396) Phase 2 single-arm clinical study evaluating tisotumab vedotin as monotherapy in patients with previously treated recurrent or metastatic cervical cancer </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 7/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">In addition to a Phase 3 study in recurrent or metastatic cervical cancer, multiple</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> Phase 2 clinical studies in other solid tumors are ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed and co-promoted in the U.S. in collaboration with Seagen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 4.5pt 11pt 0pt;">Tivdak is an ADC composed of Genmab&#8217;s human monoclonal antibody directed to TF and Seagen&#8217;s ADC technology that utilizes a protease-cleavable linker that covalently attaches the microtubule-disrupting agent monomethyl auristatin E to the antibody. Genmab used technology licensed from Medarex to generate the TF antibody forming part of Tivdak. Tivdak is the first and only U.S. FDA approved ADC for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Tivdak is being co-developed by Genmab and Seagen. Under a joint commercialization agreement, Genmab is co-promoting Tivdak in the U.S. and will lead commercial operational activities in Japan. Seagen is leading commercial operational activities in the U.S. and will lead commercial operational activities in Europe and China. In these four markets there will be a 50:50 cost and profit split. In any other markets, Seagen will commercialize Tivdak and Genmab will receive royalties based on a percentage of aggregate net sales ranging from the mid-teens to the mid-twenties. The companies have joint decision-making on the worldwide development and commercialization strategy for Tivdak. The companies have a broad clinical development program for Tivdak, including a confirmatory Phase 3 study in recurrent or metastatic cervical cancer.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> for Tivdak for the labeled indication and safety information, including the boxed warning.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2022 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">March: Genmab and Seagen presented interim data from two cohorts of the Phase 1b/2 innovaTV 205 (NCT03786081) study of tisotumab vedotin as a virtual oral presentation at the Society of Gynecologic Oncology Annual Meeting on Women&#8217;s Cancer. The ongoing innovaTV 205 study is evaluating tisotumab vedotin as monotherapy and in combination with other agents in recurrent or metastatic cervical cancer.  </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">February: Genmab and Seagen presented preliminary data from the Phase 2 innovaTV 207 (NCT03485209) study of tisotumab vedotin as part of a plenary session at</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> t</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">he American Society for Radiation Oncology (ASTRO) 2022 Multidisciplinary Head and Neck Cancers Symposium. The ongoing innovaTV 207 study is evaluating the activity, safety and tolerability of tisotumab vedotin in selected solid tumors with high TF expression. The data presented at ASTRO was from the squamous cell carcinoma of the head and neck (SCCHN) cohort of the study, which is evaluating tisotumab vedotin monotherapy in patients with SCCHN who experienced disease progression on or after a first-line platinum-containing regimen and a checkpoint inhibitor.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Epcoritamab (DuoBody-CD3xCD20) &#8211; Potential Best-in-class Investigational Medicine</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody-based investigational medicine created with Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Five ongoing clinical studies across different settings and histologies, including a Phase 3 study in relapsed / refractory diffuse large B-cell lymphoma (DLBCL) with more studies in planning</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffffff;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab is a proprietary bispecific antibody created using Genmab&#8217;s DuoBody technology platform. Epcoritamab targets CD3, which is expressed on T-cells, and CD20, a clinically well-validated target on malignant B-cells. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of epcoritamab. Epcoritamab is being co-developed by Genmab and AbbVie. The first Phase </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 8/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">3 clinical study (NCT04628494) of epcoritamab in relapsed / refractory DLBCL is ongoing. In addition, Phase 1/2 clinical studies in B-cell non-Hodgkin lymphoma (B-NHL) including chronic lymphocytic leukemia (NCT04623541) and in combination with standard of care therapies for B-NHL (NCT04663347) are ongoing. The combination of epcoritamab and DuoHexaBody<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup>-CD37 (GEN3009) is also being explored in an arm of a Phase 1/2 clinical study (NCT04358458) of DuoHexaBody-CD37 in hematologic malignancies.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2022 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">March: The U.S. FDA granted orphan-drug designation to epcoritamab for the treatment of FL. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-PD-L1x4-1BB (GEN1046) &#8211; Bispecific Next Generation Checkpoint Immunotherapy</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody-based investigational medicine created with Genmab&#8217;s DuoBody technology platform </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Clinical studies in solid tumors ongoing, including a Phase 2 study in non-small cell lung cancer (NSCLC)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-PD-L1x4-1BB (GEN1046) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology platform. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for DuoBody-PD-L1x4-1BB on a 50:50 basis. DuoBody-PD-L1x4-1BB is designed to induce an antitumor immune response by simultaneous and complementary PD-L1 blockade and conditional 4-1BB stimulation using inert DuoBody antibody format. Three clinical studies in solid tumors are ongoing including a Phase 2 study of DuoBody-PD-L1x4-1BB as monotherapy or in combination with pembrolizumab in patients with recurrent metastatic NSCLC (NCT05117242).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD40x4-1BB (GEN1042) &#8211; Potential First-in-Class Bispecific Agonistic Antibody</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody-based investigational medicine created with Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical study in solid tumors ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD40x4-1BB (GEN1042) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology platform. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for DuoBody-CD40x4-1BB on a 50:50 basis. CD40 and 4-1BB were selected as targets to enhance both dendritic cells and antigen-dependent T-cell activation, using an inert DuoBody format. A Phase 1/2 clinical study of DuoBody-CD40x4-1BB in solid tumors is ongoing (NCT04083599).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoHexaBody-CD37 (GEN3009) &#8211; First DuoHexaBody Program in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Antibody-based investigational medicine created with Genmab&#8217;s DuoHexaBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical study in hematologic malignancies ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Co-developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoHexaBody-CD37 (GEN3009) is a bispecific antibody that targets two non-overlapping CD37 epitopes, created using Genmab&#8217;s DuoHexaBody technology platform. The DuoHexaBody technology platform combines the dual targeting of our DuoBody technology platform with the enhanced potency of our </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 9/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody technology platform, creating bispecific antibodies with target-mediated enhanced hexamerization. DuoHexaBody-CD37 is being co-developed by Genmab and AbbVie. A Phase 1/2 clinical study (NCT04358458) in hematologic malignancies, including an arm in combination with epcoritamab, is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">HexaBody-CD38 (GEN3014) &#8211; HexaBody Molecule with Potential in Hematological Malignancies</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Antibody-based investigational medicine created with Genmab&#8217;s HexaBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical study in hematological malignancies ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed in an exclusive worldwide license and option agreement with Janssen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody-CD38 (GEN3014) is a human CD38 monoclonal antibody-based investigational medicine created using Genmab&#8217;s HexaBody technology platform. In preclinical models of hematological malignancies HexaBody-CD38 demonstrated highly potent complement-dependent cytotoxicity and showed potent anti-tumor activity. In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen to develop and commercialize HexaBody-CD38. A Phase 1/2 clinical study (NCT04824794) in hematologic malignancies is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD3xB7H4 (GEN1047) &#8211; Most Recent Investigational Medicine in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Bispecific antibody-based investigational medicine created with Genmab&#8217;s DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Phase 1/2 clinical study in malignant solid tumors ongoing</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;background:#ffffff;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD3xB7H4 (GEN1047) is a bispecific antibody-based investigational medicine created using Genmab&#8217;s DuoBody technology platform. B7H4 is an immune checkpoint protein expressed on malignant cells in various solid cancers including breast, ovarian and lung cancer. In preclinical studies, DuoBody-CD3xB7H4 induced T-cell mediated cytotoxicity of B7H4-positive tumor cells. DuoBody-CD3xB7H4 is being developed for the potential treatment of solid cancer indications known to express B7H4. A Phase 1/2 clinical study (NCT05180474) of DuoBody-CD3xB7H4 in malignant solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Quarter 2022 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">January: The first patient was dosed in the first-in-human Phase 1/2 study of DuoBody-CD3xB7H4 in patients with malignant solid tumors.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Products Powered by Genmab&#8217;s Technology and Innovations</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:10pt;">In addition to Genmab&#8217;s own pipeline of investigational medicines, our innovations and proprietary technology platforms are applied in the pipelines of global pharmaceutical and biotechnology companies. These companies are running clinical development programs with antibodies created by Genmab or created using Genmab&#8217;s proprietary DuoBody bispecific antibody technology platform. The programs run from Phase 1 development to approved medicines. The tables in this section include those therapies that have been approved in certain territories as well as clinical stage investigational medicines in Phase 2 development or later. Under the agreements for these products Genmab is entitled to certain potential milestones and royalties.</font> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 10/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Approved Medicines</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><img src="tmb-20220511xex99d1006.jpg" alt="Graphical user interface, application, table&#10;&#10;Description automatically generated with medium confidence" style="display:inline-block;height:202.05pt;left:0%;padding-bottom:0.45pt;position:relative;top:0pt;width:468pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">*</sup>See local country prescribing information for precise indications and safety information</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DARZALEX (daratumumab) &#8211; Redefining the Treatment of Multiple Myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First-in-class human CD38 monoclonal antibody</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed and commercialized by Janssen under an exclusive worldwide license from Genmab </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Intravenous (IV) formulation approved in combination with other therapies for frontline and for relapsed / refractory multiple myeloma in territories including the U.S., Europe and Japan and as monotherapy for heavily pretreated or double-refractory multiple myeloma in territories including the U.S. and Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First and only SC CD38-directed antibody approved in territories including the U.S., Europe and Japan for the treatment of certain multiple myeloma indications, known as DARZALEX </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;">FASPRO</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> (daratumumab and hyaluronidase-fihj) in the U.S., and DARZALEX SC in Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">SC daratumumab is the first and only approved therapy for light-chain (AL) amyloidosis in the U.S., Europe and Japan</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Net sales of DARZALEX by Janssen were USD 1,856 million in the first three months of 2022</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DARZALEX is a human monoclonal antibody that binds with high affinity to the CD38 molecule, which is highly expressed on the surface of multiple myeloma cells and is also expressed by AL amyloidosis plasma cells. Genmab used technology licensed from Medarex to generate the CD38 antibody forming part of daratumumab. Daratumumab is being developed by Janssen under an exclusive worldwide license from Genmab to develop, manufacture and commercialize daratumumab. Under the terms of the agreement, Genmab is entitled to double digit royalties between 12% and 20%. Daratumumab (marketed as DARZALEX for IV administration and as DARZALEX <i style="font-style:italic;">FASPRO </i>in the United States and as DARZALEX SC in Europe for SC administration) is approved in a large number of territories for the </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 11/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">treatment of adult patients with certain multiple myeloma indications and is the only<i style="font-style:italic;"> </i>approved therapy in the U.S., Europe and Japan for the treatment of adult patients with AL amyloidosis.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the <font style="color:#029c93;">European Summary of Product Characteristics</font><font style="color:#029c93;"> </font>for DARZALEX and DARZALEX SC and the <font style="color:#029c93;">U.S. Prescribing Information</font> for DARZALEX <i style="font-style:italic;">FASPRO</i><b style="color:#0070c0;font-size:13pt;font-weight:bold;"> </b>for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Kesimpta (ofatumumab) &#8211; Approved in treatment of relapsing forms of multiple sclerosis (RMS)</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Human CD20 monoclonal antibody developed and commercialized by Novartis Pharma AG (Novartis) under a license agreement with Genmab</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Approved in territories including the U.S., EU and Japan for treatment of RMS in adults</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First B-cell therapy that can be self-administered by patients at home using the Sensoready</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> autoinjector pen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Kesimpta is a human monoclonal antibody that targets an epitope on the CD20 molecule encompassing parts of the small and large extracellular loops. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of Kesimpta. Kesimpta is approved in territories including the U.S., Europe and Japan for the treatment of certain adult patients with RMS. Kesimpta is the first B-cell therapy that can be self-administered by patients at home using the Sensoready autoinjector pen, once monthly after starting therapy. Kesimpta is being developed and marketed worldwide by Novartis under a license agreement between Genmab and Novartis. Under the terms of the agreement, Genmab is entitled to 10% royalties on net sales of Kesimpta.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the <font style="color:#029c93;">European Summary of Product Characteristics</font> for the labeled indication and safety information for Kesimpta. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TEPEZZA (teprotumumab-trbw) &#8211; First U.S. FDA-approved medicine for the treatment of thyroid eye disease (TED)</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Developed and commercialized by Horizon Therapeutics, plc (Horizon) for TED</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First and only U.S. FDA-approved medicine for the treatment of TED</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Also being explored in diffuse cutaneous systemic sclerosis (dcSSC)</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">Teprotumumab, approved by the U.S. FDA under the trade name TEPEZZA, is a human monoclonal antibody that targets the Insulin-like Growth Factor 1 Receptor (IGF-1R), a well-validated target. Genmab used technology licensed from Medarex to generate the IGF-1R antibody forming part of teprotumumab.  The antibody was created by Genmab under a collaboration with Roche and development and commercialization of the product is now being conducted by Horizon under a sublicense from Roche. Under the terms of Genmab&#8217;s agreement with Roche, Genmab will receive mid-single digit royalties on sales of TEPEZZA. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> for the labeled indication and safety information for TEPEZZA.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">RYBREVANT (amivantamab-vmjw) &#8211; First regulatory approvals for a DuoBody-based Medicine</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Part of Genmab and Janssen DuoBody research and license agreement</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">First approved medicine created using Genmab&#8217;s proprietary DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Under the agreement with Janssen, Genmab will receive milestones and royalties on net sales of RYBREVANT</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 12/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">In July 2012, Genmab entered into a collaboration with Janssen to create and develop bispecific antibodies using Genmab&#8217;s DuoBody technology platform. The most advanced of these, Janssen&#8217;s RYBREVANT, is a fully human bispecific antibody that targets epidermal growth factor receptor (EGFR) and Met, two validated cancer targets. The two antibody libraries used to produce amivantamab were both generated by Genmab. In collaboration with Janssen, the antibody pair used to create amivantamab was selected. Janssen is responsible for the development of amivantamab. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">In 2021, Janssen received approvals in the U.S., Europe and other markets for RYBREVANT for the treatment of certain adult patients with NSCLC with EGFR exon 20 insertion mutations. These are the first regulatory approvals for a therapy that was created using Genmab&#8217;s proprietary DuoBody bispecific technology platform. Under our agreement with Janssen, Genmab will receive milestones and royalties between 8% and 10% on net sales of RYBREVANT.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Please consult the <font style="color:#029c93;">U.S. Prescribing Information</font> and the<font style="color:#029c93;"> European Summary of Product Characteristics</font> for RYBREVANT for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Clinical Stage Investigational Medicines, &gt;Phase 2 Development</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Georgia';font-weight:bold;"><img src="tmb-20220511xex99d1007.jpg" alt="A picture containing graphical user interface&#10;&#10;Description automatically generated" style="display:inline-block;height:148.5pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;"><sup style="font-size:6pt;vertical-align:super;">*</sup><font style="vertical-align:super;">UltiMab</font><sup style="font-size:6pt;vertical-align:super;"> </sup><font style="vertical-align:super;">transgenic mouse technology licensed from Medarex, Inc., a wholly owned subsidiary of Bristol Myers Squibb.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Preclinical Programs</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Broad preclinical pipeline that includes both partnered products and in-house programs based on our proprietary technologies or antibodies</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Multiple new IND applications expected to be submitted over coming years</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">Genmab has entered multiple strategic collaborations to support the expansion of our innovative pipeline</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Our preclinical pipeline includes immune effector function enhanced antibodies developed with our HexaBody technology platform and bispecific antibodies created with our DuoBody technology platform. We are also working with our partners to generate additional new antibody-based product concepts. A number of the preclinical programs are carried out in cooperation with our collaboration partners.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 13/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_SIGNIFICANT_RISKS_AND"></a></b><b style="color:#029c93;font-weight:bold;">SIGNIFICANT RISKS AND UNCERTAINTIES</b><b style="font-size:16pt;font-weight:bold;"><a name="SIGNIFICANTRISKSANDUNCERTAINTIES_402181"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As a biotech company, Genmab faces a number of risks and uncertainties. These are common for the industry and relate to operations, intellectual property, research and development, commercialization and financial activities. For further information about risks and uncertainties which Genmab faces, refer to the 2021 Annual Report filed with NASDAQ Copenhagen and the Form 20-F filed with the SEC, both of which were filed in February 2022. At the date of this interim report, there have been no significant changes to Genmab&#8217;s overall risk profile since the publication of these reports; however, the full extent and nature of the impact of the COVID-19 pandemic and related containment measures on our business and financial performance is uncertain. See Genmab&#8217;s Form 20-F for a detailed summary of risks related to our collaborations as well as risks related to the COVID-19 pandemic. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK15"></a><a name="OLE_LINK16"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 14/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">FINANCIAL REVIEW</b><b style="font-size:16pt;font-weight:bold;"><a name="FINANCIALREVIEW_601130"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK6"></a><a name="OLE_LINK7"></a>The interim report is prepared on a consolidated basis for the Genmab group. The financial statements are published in Danish Kroner (DKK).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s revenue was DKK 2,119 million for the first three months of 2022 compared to DKK 1,581 million for the first three months of 2021. The increase of DKK 538 million, or 34%, was primarily driven by higher DARZALEX, TEPEZZA and Kesimpta royalties achieved under our collaborations with Janssen, Roche and Novartis, respectively, partly offset by milestones achieved under our collaborations with AbbVie and Janssen in the first three months of 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.99%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,836</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,017</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 135</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 110</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 111</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 454</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Collaboration revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 37</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,119</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Royalties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue amounted to DKK 1,836 million in the first three months of 2022 compared to DKK 1,017 million in the first three months of 2021. The increase of DKK 819 million, or 81%, was primarily driven by higher DARZALEX, TEPEZZA and Kesimpta royalties achieved under our daratumumab collaboration with Janssen, teprotumumab collaboration with Roche and ofatumumab collaboration with Novartis. The table below summarizes Genmab&#8217;s royalty revenue by product. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:18.99%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">DARZALEX </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,501</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 984</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">TEPEZZA </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 199</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Kesimpta </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 129</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total royalties</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.99%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,836</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,017</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of DARZALEX by Janssen were USD 1,856 million in the first three months of 2022 compared to USD 1,365 million in the first three months of 2021. The increase of USD 491 million, or 36%, was driven by the continued strong uptake of DARZALEX. Royalty revenue on net sales of DARZALEX<sup style="font-size:7.5pt;vertical-align:top;"> </sup>was DKK 1,501 million in the first three months of 2022 compared to DKK 984 million in the first three months of 2021, an increase of DKK 517 million. The percentage increase in royalties of 53% is higher than the percentage increase in the underlying net sales primarily due to higher average exchange rate between the USD and DKK and a higher effective royalty rate for the first three months of 2022, partly offset by the increase in Janssen&#8217;s royalty payments to Halozyme in connection with SC sales. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">TEPEZZA was launched by Horizon in the first quarter of 2020. Royalties, which are based on net sales, amounted to DKK 199 million during the first three months of 2022 compared to DKK 2 million in the first three months of 2021. TEPEZZA sales in the first three months of 2021 were impacted by the U.S. government-mandated COVID-19 production interruption.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 15/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Novartis was granted U.S. FDA approval for Kesimpta in RMS and Genmab started recognizing royalties on net sales of Kesimpta during the third quarter of 2020. Royalties, which are based on net sales, amounted to DKK 129 million for the first three months of 2022 compared to DKK 31 million for the first three months of 2021. The increase of DKK 98 million was driven by increased net sales of Kesimpta.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Janssen was granted U.S. FDA approval for RYBREVANT, a fully human bispecific antibody that targets EGFR and Met, and Genmab started recognizing royalties on net sales of RYBREVANT during the second quarter of 2021. Royalties were not material for the first three months of 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue fluctuations from period to period are due primarily to the level of product net sales as well as foreign currency exchange rates. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reimbursement Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Reimbursement revenue amounted to DKK 135 million in the first three months of 2022 compared to DKK 110 million in the first three months of 2021. The increase of DKK 25 million, or 23%, was primarily driven by higher activities under our collaboration agreement with BioNTech for DuoBody-PD-L1x4-1BB and DuoBody-CD40x4-1BB. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Milestone Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk14190762"></a>Milestone revenue was DKK 111 million in the first three months of 2022 compared to DKK 454 million in the first three months of 2021, a decrease of DKK 343 million, or 76%, primarily driven by milestones achieved in the first three months of 2021 under our AbbVie and Janssen collaborations.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Milestone revenue may fluctuate significantly from period to period due to both the timing of achievements and the varying amount of each individual milestone under our license and collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Collaboration Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2021, Genmab and Seagen announced U.S. FDA accelerated approval for Tivdak in previously treated recurrent or metastatic cervical cancer. Collaboration revenue was DKK 37 million for the first three months of 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 2 in this interim report for further details about revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Research and Development Costs</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs amounted to DKK 1,153 million in the first three months of 2022 compared to DKK 848 million in the first three months of 2021. The increase of DKK 305 million, or 36%, was driven by the continued advancement of epcoritamab under our collaboration with AbbVie, continued advancement of DuoBody-PD-L1x4-1BB and DuoBody-CD40x4-1BB under our collaboration with BioNTech, and the increase in new team members to support the expansion of our product pipeline. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs accounted for 72% of total operating expenses in the first three months of 2022 compared to 81% in the first three months of 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Selling, General and Administrative Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses were DKK 452 million in the first three months of 2022 compared to DKK 201 million in the first three months of 2021. The increase of DKK 251 million, or 125%, was driven by the increase in new team members to support Tivdak post launch, continued expansion of </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 16/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">commercialization capabilities, investment in Genmab&#8217;s broader organizational infrastructure, including technology and systems.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses accounted for 28% of total operating expenses in the first three months of 2022 compared to 19% in the first three months of 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Profit </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Operating profit was DKK 514 million in the first three months of 2022 compared to DKK 532 million in the first three months of 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Financial Items</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net financial items were comprised of the following:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 36</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Gain on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 123</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Foreign exchange rate gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 401</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 783</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 437</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 968</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (4)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3)</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss on marketable securities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (189)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (73)</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Loss on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (146)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (339)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (76)</b></p></td></tr><tr><td style="vertical-align:bottom;width:60.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 98</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net financial items decreased by DKK 794 million, or 89%, which were primarily driven by: </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">A decrease in foreign exchange rate gain, net due to </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">USD strengthening against the DKK which was more favorable to our marketable securities and cash in the first three months of 2021,</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">The loss on other investments due to the decrease in fair value of Genmab&#8217;s investments in common shares of CureVac and Bolt, and </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">A loss on marketable securities driven by increases in interest rates in the United States and Europe. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 4 in this interim report for further details about the net financial items.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk100929385"></a><b style="color:#029c93;font-weight:bold;">Corporate Tax</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax expense for the first three months of 2022 was DKK 147 million compared to DKK 328 million for the first three months of 2021. The decrease in corporate tax expense is primarily the result of Genmab&#8217;s lower net result before tax. The effective tax rate in the first three months of 2022 was 24% compared to 23% in the first three months of 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 17/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Profit </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net profit for the first three months of 2022 was DKK 465 million compared to DKK 1,096 million in the first three months of 2021. The decrease was driven by the items described above. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Liquidity and Capital Resources</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.13%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.13%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,917</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,381</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.13%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,071</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,957</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.13%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,719</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 22,196</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:17.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash Flow (DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">3 Months Ended March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 587</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (667)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (579)</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (64)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (220)</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash provided by operating activities is primarily related to our operating profit, changes in operating assets and liabilities, reversal of net financial items, and adjustments related to non-cash transactions. The primary driver of lower cash provided by operating activities was due the timing of corporate tax payments of DKK 455 million in Denmark in the first three months of 2022 that were not required in the first three months of 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in investing activities primarily reflects differences between the proceeds received from the sale and maturity of our investments and amounts invested, and the cash paid for investments in tangible assets. Purchases of marketable securities exceeded sales and maturities in both periods, but to a greater extent in the first three months of 2021. For the first three months of 2021, investing activities also includes the proceeds from the sale of CureVac shares of DKK 361 million. There were no sales of other investments in the first three months of 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in financing activities is primarily related to the exercise of warrants, purchase of treasury shares, lease payments, and payment of withholding taxes on behalf of employees on net settled Restricted Stock Units (RSUs). The decrease in cash used in financing activities for the periods is primarily driven by cash payments for the purchase of treasury shares of DKK 190 million in the first three months of 2021. There were no purchases of treasury shares in the first three months of 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s USD denominated cash and cash equivalents, and marketable securities was 86% of Genmab&#8217;s total cash and cash equivalents, and marketable securities as of March 31, 2022 and December 31, 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cash and cash equivalents included short-term marketable securities of DKK 559 million as of March 31, 2022 compared to DKK 296 million as of December 31, 2021. In accordance with our accounting policy, securities purchased with a maturity of less than ninety days at the date of acquisition are classified as cash and cash equivalents. Refer to Financial Statement Note 3 in this interim report for further details about our marketable securities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 18/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Balance Sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2022, total assets were DKK 24,914 million compared to DKK 24,627 million on December 31, 2021. As of March 31, 2022, assets were mainly comprised of marketable securities of DKK 10,917 million, cash and cash equivalents of DKK 9,071 million and current receivables of DKK 2,846 million. The current receivables consist primarily of amounts related to royalties from our collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2022, total liabilities were DKK 2,195 million compared to DKK 2,431 million on December 31, 2021. The decrease in total liabilities of DKK 236 million, or 10%, was <font style="background:#ffffff;">primarily driven by timing of payments related to accounts payable and higher accrued compensation related to annual bonuses paid in the first three months of 2022.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Shareholders&#8217; equity as of March 31, 2022 was DKK 22,719 million compared to DKK 22,196 million on December 31, 2021. The increase of DKK 523 million, or 2%, was driven primarily by Genmab&#8217;s net profit and share-based compensation expense related to the issuance of shares under Genmab&#8217;s warrant and RSU programs, partly offset by the net settlements of RSUs vested during the period. Genmab&#8217;s equity ratio was 91% as of March 31, 2022 compared to 90% as of December 31, 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Team Members</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2022, the total number of team members was 1,309 compared to 871 as of March 31, 2021. The increase was primarily driven by the expansion and acceleration of our pipeline, as well as the investment in the expansion of commercialization capabilities, including support for Tivdak post launch, and broader organizational infrastructure.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Team Members</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development team members</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 954</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 709</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative team members</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 355</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 162</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total team members</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,309</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 871</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Legal Matter &#8211; Janssen Binding Arbitration </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for IV administration and as DARZALEX FASPRO in the United States and as DARZALEX SC in Europe for SC administration). In April 2022, the arbitral tribunal issued an award in the binding arbitration of the two matters. Genmab did not seek a review of the award, and the award is now final.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 19/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">The first matter concerned the question as to whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement.  As to that matter, the tribunal determined by majority opinion that Janssen&#8217;s obligation to pay royalties to Genmab on sales of licensed product, in each applicable country, extends through the expiration or invalidation of the last-to-expire relevant Genmab-owned patent covering the product or use thereof, but not the relevant Janssen-owned patent. The relevant Genmab-owned issued U.S., European and Japanese patents will expire in the late 2020s and early 2030s. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The second matter concerned the question as to whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme for the Halozyme enzyme technology used in the SC formulation of daratumumab (marketed as DARZALEX FASPRO<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup> in the U.S.). The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of SC daratumumab sales. As to that matter, the tribunal ruled by majority opinion that Janssen is permitted to continue reducing its royalty payments to Genmab as an offset against a share of Janssen&#8217;s royalty payments made to Halozyme. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 20/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="Statementsofcomprehensiveincome"></a><b style="color:#029c93;font-weight:bold;">STATEMENTS OF COMPREHENSIVE INCOME</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2021</p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,119</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,153)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (848)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (452)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (201)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,605)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,049)</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating profit</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 514</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 532</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial income</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 437</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 968</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial expenses</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (339)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (76)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net profit before tax</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 612</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,424</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (147)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (328)</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net profit</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 465</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,096</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Basic net profit per share</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.10</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.76</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Diluted net profit per share</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7.05</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16.61</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Comprehensive Income</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net profit</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 465</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,096</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other comprehensive income:</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts which will be re-classified to the income statement:</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Adjustment of foreign currency fluctuations on subsidiaries</p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:59.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;width:5.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.26%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 481</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,137</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514648"></a><a name="_MON_1411968110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 21/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="STATEMENTOFCOMPREHENSIVEINCOMEFORTHEFIRS"></a><a name="FIRSTNINEMONTHSOF2019_377366"></a><b style="color:#029c93;font-weight:bold;">BALANCE SHEET</b><a name="BALANCESHEET_757698"></a><b style="color:#029c93;font-weight:bold;">S</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">March&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 234</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 254</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Property and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 632</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 621</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 343</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 354</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 264</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 264</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 239</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 371</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,739</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,891</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 341</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,846</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,367</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,917</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,381</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,071</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,957</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 23,175</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,736</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 24,914</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 24,627</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">SHAREHOLDERS&#8217; EQUITY AND LIABILITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,044</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,029</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 97</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 81</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,512</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,020</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,719</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,196</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 356</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 363</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 856</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 863</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 60</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,253</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,480</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,339</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,568</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,195</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,431</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 24,914</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 24,627</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based instruments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:52.65%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Subsequent events to the balance sheet date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1411968448"></a><a name="_MON_1428926110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 22/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENTS OF CASH FLOWS</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCASHFLOWS_489627"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:8.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">March 31, 2021</p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net profit before tax</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 612</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,424</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Reversal of financial items, net</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (98)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (892)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Adjustments for non-cash transactions</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 159</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 117</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Changes in operating assets and liabilities</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 334</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flows from operating activities before financial items</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,007</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,149</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest received</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 38</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest elements of lease payments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest paid</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Corporate taxes paid</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (455)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash provided by operating activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 587</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,185</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (57)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (28)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities bought</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,993)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,673)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities sold</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,391</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,769</font></p></td></tr><tr><td style="vertical-align:middle;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments bought</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8)</font></p></td></tr><tr><td style="vertical-align:middle;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments sold</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 361</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash (used in) investing activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (667)</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (579)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Warrants exercised</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Principal elements of lease payments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (16)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (12)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (190)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Payment of withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (63)</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net cash (used in) financing activities</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (64)</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (220)</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Change in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (144)</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 386</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,957</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Exchange rate adjustments</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 258</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 246</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,071</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,892</b></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents include:</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Bank deposits</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,512</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,954</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Short-term marketable securities</p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 559</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,938</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:53.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.48%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,071</b></p></td><td style="vertical-align:bottom;width:2.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,892</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 23/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENTS OF CHANGES IN EQUITY</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCHANGESINEQUITY_43137"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Translation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Retained</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Shareholders&#39;</p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">equity</p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,894</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 54</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,107</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,121</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 41</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,096</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,137</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (206)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (206)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 61</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (38)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at March 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,914</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 95</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 20,095</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,029</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 81</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,196</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net profit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 465</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 465</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 465</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 481</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (63)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (63)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at March 31, 2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 12,044</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 97</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,512</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 22,719</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 24/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">NOTES TO THE FINANCIAL STATEMENTS</b><b style="font-size:16pt;font-weight:bold;"><a name="NOTESTOTHEFINANCIALSTATEMENTS_435403"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 1 &#8211; Basis of Presentation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Accounting Policies</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">These interim statements of the Genmab group (Genmab or the Company) have been prepared in accordance with IAS 34 as issued by the International Accounting Standards Board (IASB) and in accordance with IAS 34 as endorsed by the EU and additional Danish disclosure requirements for interim reports of listed companies. The interim report has not been reviewed or audited by Genmab&#8217;s external auditors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The interim report has been prepared using the same accounting policies as outlined in Section 1 &#8211; Basis of Presentation in the financial statements in the Genmab 2021 Annual Report (Annual Report). A number of new or amended standards became applicable for the current reporting period. Genmab was not required to change its accounting policies as a result of adopting these standards. These interim financial statements should be read in conjunction with the Annual Report. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Management Judgements and Estimates under IFRS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In preparing interim reports, certain provisions under IFRS require management to make judgements (various accounting estimates and assumptions), which may significantly impact the group&#8217;s financial statements. For a description of significant judgements and estimates, refer to Note 1.3 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Information about Geographical Areas</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is managed and operated as one business unit, which is reflected in the organizational structure and internal reporting. No separate lines of business or separate business entities have been identified with respect to any licensed products, product candidates or geographical markets and no segment information is currently prepared for internal reporting. Refer to Note 2.2 in the Annual Report for further details.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 25/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1428926213"></a><a name="_MON_1428393242"></a><b style="color:#029c93;font-weight:bold;">Note 2 &#8211; Revenue </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below summarizes Genmab&#8217;s revenue by type and collaboration partner, and royalties by product, under Genmab&#8217;s agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">March 31, 2021</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Revenue by type:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,836</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,017</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 135</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 110</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 111</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 454</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Collaboration revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 37</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,119</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Revenue by collaboration partner:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,608</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,193</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">AbbVie</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 245</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Roche</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 199</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Novartis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 129</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">BioNTech</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 119</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Seagen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 53</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,119</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,581</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Royalties by product:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">DARZALEX </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,501</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 984</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">TEPEZZA </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 199</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kesimpta </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 129</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 31</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,836</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,017</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.51%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.24%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for IV administration and as DARZALEX FASPRO in the United States and as DARZALEX SC in Europe for SC administration). In April 2022, the arbitral tribunal issued an award in the binding arbitration of the two matters. Genmab did not seek a review of the award, and the award is now final.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;">The first matter concerned the question as to whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement.  As to that matter, the tribunal determined by majority opinion that Janssen&#8217;s obligation to pay royalties to Genmab on sales of licensed product, in each applicable country, extends through the expiration or invalidation of the last-to-expire relevant Genmab-owned patent covering the product or use thereof, but not the relevant Janssen-owned patent. The relevant Genmab-owned issued U.S., European and Japanese patents will expire in the late 2020s and early 2030s. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 26/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The second matter concerned the question as to whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme for the Halozyme enzyme technology used in the SC formulation of daratumumab (marketed as DARZALEX FASPRO<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup> in the U.S.). The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of SC daratumumab sales. As to that matter, the tribunal ruled by majority opinion that Janssen is permitted to continue reducing its royalty payments to Genmab as an offset against a share of Janssen&#8217;s royalty payments made to Halozyme. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 2.1 in the Annual Report for further details regarding revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk100827949"></a><a name="_Hlk100828495"></a><b style="color:#029c93;font-weight:bold;">Note 3 &#8211; Financial Instruments</b> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s portfolio is spread over a number of different securities with a focus on liquidity and the preservation of capital. Genmab&#8217;s marketable securities in USD, DKK, EUR, and GBP as a percentage of total marketable securities was as follows: </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31,</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Percent</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 76</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 75</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DKK</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GBP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of March 31, 2022, 71% of Genmab&#8217;s marketable securities were long-term A rated or higher, or short-term A-1 / P-1 rated by S&amp;P, Moody&#8217;s or Fitch compared to 68% as of December 31, 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below shows the fair value measurements by level for Genmab&#8217;s financial assets measured at fair value through profit or loss:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:25.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:39.56%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, 2022</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:30.71%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2021</b></p></td></tr><tr><td style="vertical-align:middle;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Assets Measured at Fair Value</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:middle;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,917</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.66%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.18%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,917</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,381</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10,381</p></td></tr><tr><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.66%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">201</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.66%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">38</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 239</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">344</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">27</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">371</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Marketable Securities</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">All fair values are determined by reference to external sources using unadjusted quoted prices in established markets for Genmab&#8217;s marketable securities (Level 1). </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Investments </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments as of March 31, 2022 consist primarily of a DKK 186 million investment in common shares of CureVac, compared to DKK 318 million as of December 31, 2021. During the second quarter of 2021, Genmab made an investment in common shares of Bolt. As of March 31, 2022, the investment in Bolt was valued at DKK 15 million, compared to DKK 26 million as of December 31, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 27/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The investments in CureVac and Bolt are recorded at fair value through profit or loss. The fair value of Genmab&#8217;s investments in CureVac and Bolt are determined using unadjusted quoted prices in established markets (Level 1).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.3 and Note 4.4 in the Annual Report for further details regarding Genmab&#8217;s marketable securities and other investments.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk100837392"></a><b style="color:#029c93;font-weight:bold;">Note 4 &#8211; Financial Income and Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2021</p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 36</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Gain on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 123</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 401</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 783</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 437</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 968</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (4)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3)</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on marketable securities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (189)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (73)</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (146)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (339)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (76)</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.12%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 98</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.73%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net was DKK 401 million in the first three months of 2022 compared to DKK 783 million in the first three months of 2021. The USD strengthened against the DKK in each period which positively impacted our USD denominated marketable securities and cash holdings, but to a greater extent in 2021. Refer to Note 4.2 in the Annual Report for further details regarding foreign currency risk. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background:#ffffff;">Loss on other investments, net was DKK 146 million in the first three months of 2022 compared to gain on other investments, net of DKK 123 million in the first three months of 2021. The change was driven&#160;by the decrease in fair value of Genmab&#8217;s investment in common shares of CureVac and Bolt.&#160;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on marketable securities, net was DKK 189 million in the first three months of 2022 compared to DKK 73 million in the first three months of 2021. The increase in fair value losses on marketable securities was primarily driven by increases in interest rates in the United States and Europe.<font style="white-space:pre-wrap;">  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 28/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 5 &#8211; Share-Based Instruments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restricted Stock Unit Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established RSU programs as an incentive for all Genmab employees, members of the registered Executive Management, and members of the Board of Directors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">3 Months Ended</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">3 Months Ended</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">March 31, 2022</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">March 31, 2021</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">RSUs granted</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 218,434</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 128,406</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average fair value per RSU granted (DKK) </i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,185.90</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,084.65</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:57.58%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">RSUs vested</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.21%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 73,458</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 44,109</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.6 in the Annual Report for details on the RSU programs.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Warrant Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established warrant programs as an incentive for all Genmab employees, and members of the registered Executive Management.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">3 Months Ended</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">3 Months Ended</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">March 31, 2022</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.5pt;">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><font style="font-size:8.5pt;">March 31, 2021</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">Warrants granted</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 207,348</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 114,158</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average exercise price per warrant granted (DKK) </i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,186.68</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 2,122.57</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average Black-Scholes fair value per warrant granted (DKK) </i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 622.70</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 663.95</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:8.5pt;">Warrants exercised</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 15,685</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="font-size:8.5pt;white-space:pre-wrap;"> 41,574</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">Weighted average exercise price on date of grant per warrant exercised (DKK)</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 970.76</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;white-space:pre-wrap;"> 478.94</i></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:63.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><i style="font-size:8.5pt;font-style:italic;">% change in share capital - warrants exercised</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.61%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;">0.02%</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><i style="font-size:8.5pt;font-style:italic;">0.06%</i></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Note 4.6 in the Annual Report for details on the warrant programs.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share-based compensation expense</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Share-based compensation expenses related to Genmab RSU and warrant programs for the first three months of 2022 was DKK 90 million compared to DKK 61 million for the first three months of 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share repurchases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In general, Genmab intends to purchase its own shares in order to cover a portion of obligations in relation to RSUs. As of March 31, 2022, Genmab has two authorizations to repurchase shares: the 2021 and 2019 authorizations. The 2016 authorization expired in March 2021. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:50.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:14.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:15.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:14.5%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021 <br>Authorization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2019 <br>Authorization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:15.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2016 <br>Authorization</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Number of shares authorized for repurchase</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Actual shares repurchased under authorization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 170,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 255,000</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Shares available for repurchase as of March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.5%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 500,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.88%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 330,000</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first three months of 2021, Genmab acquired 100,000 of its own shares, representing approximately 0.2% of share capital. The total amount paid to acquire the shares, including directly </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 29/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">attributable costs, was DKK 206 million and was recognized as a deduction to shareholders&#8217; equity. These shares are classified as treasury shares and are presented within retained earnings on the balance sheet as of December 31, 2021. There were no share repurchases during the first three months of 2022. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">As of March 31, 2022, 239,893 treasury shares were held by Genmab to cover obligations in relation to the RSU programs and to mitigate the dilutive effect of share capital increases resulting from future exercises of warrants.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 6 &#8211; Related Parties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s related parties are Genmab A/S&#8217; (parent company) subsidiaries, Board of Directors, the registered Executive Management, and close members of the family of these persons. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has not granted any loans, guarantees or other commitments to or on behalf of any of the members of the Board of Directors or members of the registered Executive Management.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other than the remuneration and other transactions relating to the Board of Directors and the registered Executive Management described in Note&#160;5.1 in the Annual Report, there were no material related party transactions during the first three months of 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Changes to the Executive Management Team and the Board of Directors</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first three months of 2022, there were two changes to the Executive Management Team. Effective March 1, 2022, Chris Cozic was appointed Executive Vice President and Chief People Officer, and Birgitte Stephensen was appointed Executive Vice President and Chief Legal Officer. They join the existing Executive Management Team of Jan van de Winkel, President and Chief Executive Officer, Judith Klimovsky, Executive Vice President and Chief Development Officer, Anthony Pagano, Executive Vice President and Chief Financial Officer, Anthony Mancini, Executive Vice President and Chief Operating Officer, and Tahamtan Ahmadi, Executive Vice President and Chief Medical Officer. Chris Cozic and Birgitte Stephensen are not regarded as executive managers pursuant to the Danish Companies Act and will therefore not be registered with the Danish Business Authority.&#160;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Following Genmab A/S&#8217; Annual General Meeting on March 29, 2022, the Board of Directors is comprised of five independent board members, one non-independent board member, and three employee-elected board members. Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Dr. Paolo Paoletti, and Dr. Anders Gersel Pedersen were re-elected to the Board of Directors for a one-year period. Elizabeth O&#8217;Farrell was newly elected for a one-year period. Mijke Zachariasse, Martin Schultz and Takahiro Hamatani were elected to the Board of Directors by the employees for a three-year period. Peter Storm Kristensen and Rima Bawarshi Nassar stepped down from the Board of Directors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;white-space:pre-wrap;">  </i><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 30/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 7 &#8211; Leases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the balance sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The balance sheet shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31,</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 342</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 352</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 343</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 354</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 60</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 62</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 356</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 363</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.71%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 416</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.64%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 425</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first three months of 2022, there were no additions to Genmab&#8217;s right-of-use assets and lease liabilities related to the commencement of leases. During the first three months of 2021, there were additions to our right-of-use assets and lease liabilities related to the commencement of a lease in Japan with respect to office space.<font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Significant leases not yet commenced</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2020, Genmab entered into a lease agreement with respect to the new headquarters in Denmark with a commencement date in March 2023 and is non-cancellable until March 2038. The total future minimum payments over the term of the lease are approximately DKK 337 million and estimated capital expenditures to fit out the space are approximately DKK 40 million.<font style="font-family:'Times New Roman','Times','serif';font-size:12pt;"> </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2019, Genmab entered into a lease agreement with respect to office and laboratory space in the Netherlands with a commencement date in April 2022 and is non-cancellable until March 2032. Additionally, during 2021, Genmab amended this lease agreement to add additional office space in the Netherlands. The term of the amendment is the same as the original lease. The total future minimum payments over the term of the Netherlands lease (which includes the original lease and amendment for the additional space) are approximately DKK 235 million and estimated capital expenditures to fit out the space are approxi&#173;mately DKK 97 million.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 31/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the statement of comprehensive income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The statement of comprehensive income shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e6e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">March 31, 2021</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e6e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 15</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 15</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Expense relating to short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;background:#e7e6e6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.92%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense is included in net financial items and expenses relating to short-term leases are included in operating expenses in the statement of comprehensive income.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 8 - Subsequent Events to the Balance Sheet Date</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On April 8, 2022, Genmab announced an award in the binding arbitration of two matters arising under Genmab&#8217;s license agreement with Janssen relating to daratumumab. Refer to Note 2 for further details.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">No other events have occurred subsequent to the balance sheet date that could significantly affect the financial statements as of March 31, 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 32/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514653"></a></b><b style="color:#029c93;font-weight:bold;">ABOUT GENMAB</b><b style="font-size:16pt;font-weight:bold;"><a name="ABOUTGENMAB_556806"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. For more than 20 years, Genmab&#8217;s vision to transform cancer treatment has driven its passionate, innovative and collaborative teams to invent next-generation antibody technology platforms and leverage translational research and data sciences, fueling multiple differentiated cancer treatments that make an impact on people&#8217;s lives. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab&#8217;s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;"> </i><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">Genmab.com</i><i style="font-size:7.5pt;font-style:italic;"> and follow us on </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">Twitter.com/Genmab</i><i style="font-size:7.5pt;font-style:italic;">.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">This Interim Report contains forward looking statements. The words &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">www.genmab.com</i><i style="font-size:7.5pt;font-style:italic;"> and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">www.sec.gov</i><i style="font-size:7.5pt;font-style:italic;">. Genmab does not undertake any obligation to update or revise forward looking statements in this Interim Report nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:8pt;font-style:italic;">Genmab A/S and/or its subsidiaries own the following trademarks: Genmab</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:8pt;font-style:italic;">; the Y-shaped Genmab logo</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:8pt;font-style:italic;">; Genmab in combination with the </i><i style="font-size:7.5pt;font-style:italic;">Y-shaped Genmab logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HuMax&#174;; DuoBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoBody in combination with the DuoBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody in combination with the HexaBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoHexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; and HexElect</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">. </i><i style="font-size:8pt;font-style:italic;">Tivdak</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:8pt;font-style:italic;"> is a trademark of Seagen Inc.;</i><font style="font-size:10pt;"> </font><i style="font-size:8pt;font-style:italic;">EPCORE&#8482; is a trademark of AbbVie Biotechnology Ltd.; </i><i style="font-size:7.5pt;font-style:italic;">Kesimpta</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and Sensoready</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Novartis AG or its affiliates; DARZALEX</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">, DARZALEX FASPRO</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and RYBREVANT</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Johnson &amp; Johnson; TEPEZZA</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> is a trademark of Horizon Therapeutics Ireland DAC. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 33/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20220511xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Quarter of 2022</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514654"></a></b><b style="color:#029c93;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b><b style="font-size:16pt;font-weight:bold;"><a name="DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The Board of Directors and the registered Executive Management have today considered and adopted the unaudited interim report of the Genmab group for the quarter ended March 31, 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The interim report is prepared in accordance with IAS 34, &#8220;Interim Financial Reporting,&#8221; as issued by the IASB and in accordance with IAS 34 as endorsed by the EU, and additional Danish disclosure requirements for interim reports of listed companies.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">We consider the applied accounting policies to be appropriate and, in our opinion, the interim report gives a true and fair view of the assets and liabilities, financial position, results of operation and cash flows of the group.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Furthermore, we consider the Management&#8217;s Review to give a true and fair account of the development in the group&#8217;s activities and financial affairs, results of operations and the group&#8217;s financial position as a whole as well as a description of the significant risks and uncertainties which the group faces, as further described in our 2021 Annual Report and the Form 20-F filed with the U.S. Securities and Exchange Commission in February 2022.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Copenhagen, May 11, 2022</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Registered Executive Management</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1.25pt;"><td style="vertical-align:bottom;width:19.4%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:18.49%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:17.58%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;width:19.45%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:25.06%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1008.jpg" alt="A picture containing diagram&#10;&#10;Description automatically generated" style="display:inline-block;height:44.03pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:88.2pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1009.jpg" alt="A picture containing text, opener, clipart, tool&#10;&#10;Description automatically generated" style="display:inline-block;height:41.38pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:87.6pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1010.jpg" alt="A picture containing hanger&#10;&#10;Description automatically generated" style="display:inline-block;height:38.5pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:66pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1011.jpg" alt="A picture containing text, insect&#10;&#10;Description automatically generated" style="display:inline-block;height:32.3pt;left:0%;padding-bottom:0.7pt;position:relative;top:0pt;width:86.3pt;"></p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1012.jpg" alt="A picture containing sky&#10;&#10;Description automatically generated" style="display:inline-block;height:27.6pt;width:71.07pt;"></p></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jan van de Winkel</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Pagano</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Judith Klimovsky</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Mancini</p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tahamtan Ahmadi</p></td></tr><tr style="height:13.95pt;"><td colspan="2" style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(President &amp; CEO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CFO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CDO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; COO)</p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CMO)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;padding-left:28.8pt;text-indent:-28.8pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Board of Directors</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:3.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr style="height:27.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1013.jpg" alt="A close-up of a drawing&#10;&#10;Description automatically generated with low confidence" style="display:inline-block;height:28.05pt;left:0%;padding-bottom:0.45pt;position:relative;top:0pt;width:52.17pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1014.jpg" alt="Graphic" style="display:inline-block;height:24.6pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:84.87pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1015.jpg" alt="Graphic" style="display:inline-block;height:21pt;width:102pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Deirdre P. Connelly</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pernille Erenbjerg </p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anders Gersel Pedersen</p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Chair)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Deputy Chair)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1016.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:22.8pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:94.2pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1017.jpg" alt="Text&#10;&#10;Description automatically generated with low confidence" style="display:inline-block;height:24.6pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:58pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1018.jpg" alt="Text&#10;&#10;Description automatically generated with medium confidence" style="display:inline-block;height:32.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:132.6pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rolf Hoffmann</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Paolo Paoletti</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Elizabeth O&#8217;Farrell</p></td></tr><tr style="height:29.2pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1019.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:24.6pt;width:71pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1020.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:23.11pt;width:121.8pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20220511xex99d1021.jpg" alt="A close-up of a sword&#10;&#10;Description automatically generated with low confidence" style="display:inline-block;height:26.4pt;left:0%;padding-bottom:0.6pt;position:relative;top:0pt;width:55.25pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Mijke Zachariasse</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Takahiro Hamatani</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Martin Schultz</p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 17</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 34/34</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20220511xex99d1010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !- (0# 2(  A$! Q$!_\0
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>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20220511xex99d1018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !% 1,# 2(  A$! Q$!_\0
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MM2-KF^EVXA@C@16,:1J5!+'C)XR0 P/KZ"&*UAC@AC2&*-0B11J%55'   Z
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tmb-20220511xex99d1009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !4 +$# 2(  A$! Q$!_\0
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M$Y_!#N[_  Z\*S1S^(_*D*KJE\0'AL"1UC0;9)1WW(O<U] 0P1V\21QJL:*
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MF]R5[JLD=+XE\07_ .RC^SIXZ^(GBW4K=/C1XZVW4\,LX/V:XD'EVUK$N?\
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M;[L0(!QO(SVS6AXT^.7@GP'\,9?B#JGB*R7PF+<7,6HP2B2.X5ON"(C[[,>
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M>(KB_F3P19_#>S63R+*<7FJ>(S X!\QU)"P+%N..K[>0<\?;G[/?P2L_@9X
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M.D6>\.T:.^&D=V"EG('3CC&-]$W*^Y'1(]Y'>EI*6L"PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]:,]***D!:***H HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tmb-20220511xex99d1012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  Y )$# 2(  A$! Q$!_\0
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M]-T0JMY=QQ2/PD0.Z1SZ*@RQ/T% &G29 K$76=0U%%-AICQ(W_+74281CU"
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C0"WID]ZFHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tmb-20220511xex99d1008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !9 +(# 2(  A$! Q$!_\0
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M]UJ%Y;V-K']^>YE6-%^K,0!1Y 7**P-!\>^&_%$[0:/X@TO59T!+165[',P
M[X5B:W@:;33LP%HHHI %%%% !1110 4444 %%%% !1110 4444 <[XV\)?\
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M@7P$R@#_ (2/7SCN;X?_ !-'*NX:G4[EH#9/3]*Y=_ K,"/^$BUX9]+T<?\
MCM8>E? K0-*\:6WBH7FL7&LP!QYLVH/MDW#!\Q5P).G&[..U/ECU8:GHGY44
MZBL[#.?\4^$(O$YT^7[;<:?=V$_VBVN+98G*-@J?EE1U/!/.,CJ"*JOX1UAW
MR/&FKJ/06UC_ %MZZJBKYGL*QS6H>#)-3B@6?7]962,8,EM="W+_ %"*!^E.
M;P'ILMW;W4TNH37,( $CZE< -CIN57"G\171T4<S[A8P;?P/X>LK^:_@T/3X
MKV8$2W"VR>8^>NYL9.?>L-KA[N\NM)\)6D&FJORW>LQVR>3"P."B*,>9(/\
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M0>,=3EG,.@Z>Y74=0!#.AYMX!P\I^F0!ZL0*Z*QM(K"R@M85VPPQK&B^B@8
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/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tmb-20220511xex99d1020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  P /L# 2(  A$! Q$!_\0
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M;UW<I9VDTSD!(T+L3V &:QO%WC+3O!6E1WFH2/F618(((5WRSRL<*B+W)_\
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;S31G/-2"FA@3TI@/IA3)I2V#BDW>]%AV/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tmb-20220511xex99d1005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'D Z@# 2(  A$! Q$!_\0
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M=8L+?5-+NT\JXL[N,212I_=93P1[5I44 0VMI#96T5O!&L,$2"..-!A44#
M'8 5+BEHH *S?$7AO2_%VAWNC:UI]OJNE7L9AN;.[C$D4R'JK*>"*TJ* ,GP
MMX4T?P3H5IHN@:7::-I%HFRWL;&%8H8E]%50 *UJ** "DQFEHH 3%&T4M% "
M8HP*6B@!,4M%% "8HQ2T4 )@4;12T4 )@&C%+10 F!FEHHH **** "BBB@ I
M"<4M<U\2]3NM%^'?BC4+&8V][::7=3P3#'R2)"[*W/'! /- '1AE8\')^M+@
M5\0_";XJ_$2T\.>'/&,-WX^\4:='HL^I>)(_%EC;VNGN%@WQ_8Y1"C;VDX!&
MY=N2V,#/>:]^V-J_AK6H-%O_  7;'7+>RM]2U/3K34+BY=(IV/E1V[1VC+++
ML&XAS&N> QZT ?47"CVHR*^:O'G[0GB[5_AY\0];\,>'8K#0M'M=3LXM:EU)
M4OH;NWBD/FBU>/:4#KM WEN^W'27PQ\<_$6'T[3-,E\3:_>:G!IT8U?4H[6U
MA<Z?'<,X:.!F6/)Y7#MN8D''  /I#@T8Q7S?;_M/3-8VVLMH=XFIZCI]A#;:
M"^H1FU%Y/=SP!?-$6X8,3$R<@JHPF[K-\3?VF/$_PK\.V\NM^$]!M-=6.YGF
MTY_$32?:(H><VJPVSROO4$@R1QJI^\1UH ^BN":*\?\ @/\ $34?B'XB\>W-
MU/,=.BO+)]/M)@O^BQ2Z?;S%,@#/S2,<G/)]*]AH 3 HQ2T4 %)@"EJEK/V_
M^RKO^R_LXU+RF^S&[W&'S,?+OV\[<XSCG% %P8[48KRS]F[7O$/B'X<S3>*=
M676]:@UC4K.:]2W6!)!%>2QKMC7[JA5  R3@<DGFO5* $Q67XG\*Z/XTT*[T
M77M,M=8TF[4)<6-[$)895!# ,IX(R ?PK5HH 9%"D$:QHH1% 557@ #H*=2T
M4 )@4''>EKR;XU:[XOT+Q!X#?1M3M-.T"YUVVM-2C\@R75V)-X\I6/RQQ\ D
M@%B0 "HSD ]7W#UI>M?//C?Q7JNIWGB_5[WX@7'@GP-HNIQ:;-)I]NC7=P8X
M!NCMF97/F/<S!"H1F;R%5 "Q)]-^"%YXJO\ X6^'KCQI'+%XDEMMUTMQ&D<W
M+'9YJI\JR;-FX+P&W 4 =S@48%+10 F,4M%% !112'I0 9&<=Z6OGB\U?QG:
M?M :5I6E>,I_$EY)J4EQK>A16D::7HVA&&3R!(P4R+=M((BA,F9-TIV",#;]
M##.!GK0 M%%% !1110 4444 -+@'K2U\\?M+^*/%G@"6/Q7I?B/58=*L'M4E
MM--M;9[+3XS*3<76I;]TTD)C^4+" RX8@$G<OT.O H 6BBB@ HHK!\>>,+'P
M!X,UKQ'J<ODV&E6DMY,^,D(BEC@=SQTH W00>E+7QQ\%?VL=7_X0[Q4FJ7(\
M>^)[5K'4[.TMRMIF.^D5#:!F0#_1IF*;B,E63/)S7I$'[1?BB[UVX\'VO@O3
M[CQW::I_9MW:C6F6PA5K-[J.?SS!O92L;*5$>X,/3F@#W^BOFJ?]L&X32[_6
M!X-,>C:+HT^J:W-+J0\VWEBGGMFM846,^:WG0-^\)5=O/7 .])^T;K'A;6QI
M'C/PE;Z1=I/8M/-IVJ_:K>&TNY&B28LT49RDH5'7;C#A@2 < 'N])N KY8\1
M?MM3Z?<0)IO@J:]W6+ZMY<D\YEN;3SY8H!;B&WE#2RB)I LA1-I7YSDXUO$G
MQT\6^(O$'AJ70=&&E>$9/%MEHUQJ4MZHO)LE#*C6IB(6,E_+R)-X8$X P2 ?
M2(.:*.E% "?C2^O-<;_PA6O?]#YK/_@+9?\ QBC_ (0G7_\ H?=:_P# 6R_^
M,5IRK^;\SB]M5_Y]/[X_YG9>O-'XUQO_  A.O_\ 0^ZU_P" ME_\8H_X0G7_
M /H?=:_\!;+_ .,4<L?YOS#VU7_GT_OC_F=D/K1Z<UQO_"$Z_P#]#[K7_@+9
M?_&*/^$)U_\ Z'W6O_ 6R_\ C%'+'^;\P]M5_P"?3^^/^9V7IS2?C7'?\(3K
M_P#T/NM?^ ME_P#&*/\ A"=?_P"A]UK_ ,!;+_XQ1RQ_F_,/;5?^?3^^/^9V
M7XT?C7&_\(3K_P#T/NM?^ ME_P#&*/\ A"=?_P"A]UK_ ,!;+_XQ1RQ_F_,/
M;5?^?3^^/^9V7KS1Z\UQO_"$Z_\ ]#[K7_@+9?\ QBC_ (0G7_\ H?=:_P#
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M=:_\!;+_ .,57*N_YF#K5$_X3^^/^9V7XT>G-<;_ ,(3K_\ T/NM?^ ME_\
M&*/^$)U__H?=:_\  6R_^,4^6/\ -^8O;5?^?3^^/^9V7IS1^-<;_P (3K__
M $/NM?\ @+9?_&*/^$)U_P#Z'W6O_ 6R_P#C%'+'^;\P]M5_Y]/[X_YG9?C2
M?C7'?\(3K_\ T/NM?^ ME_\ &*3_ (0G7O\ H?=:_P# 6R_^,4<L?YOS'[:K
M_P ^G]\?\SL_QH]>:XS_ (0K7O\ H?=:_P# 6R_^,4O_  A.O_\ 0^ZU_P"
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M'&J>&=!U&7QC>K-?Z;;7<JI9V@4/)&K,!^ZZ9/%7?^$V\:_]#E?_ /@):?\
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M_&:Y_P"SZMVKH]U<=9<XQE[.=FDUHMFKK[1[ONI"<BO"?[1\6_\ 0[:E_P"
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M )$/PA_V ['_ -$)6I69X0_Y$/PA_P!@.Q_]$+6G7MX?^%'T/Q_/O^1IB/\
M$PHHHKH/!"BBB@ HHHH [#1/^1?L_P#KI+_,5;JIHG_(OV?_ %TE_F*MUXS^
M)^K/UZ/\&E_@A_Z2@HHHI %%%% !1110!K^&O^/F;_<_K70USWAK_CYF_P!S
M^M=#7G5OC/T+)_\ <X_/\PHHHK ]LT_#W_(0_P" &NGKF/#W_(1_X ?Z5U%>
M;B/C/O\ )?\ =/FPHHHKF/>"BBB@ I,TM4]6U:ST/3KF_P!0N8K.RMHS+-/,
MP5$4#)))Z"@3:BKLMYK$\2>--&\(K:'5K^.T:[E$%O$06DFD/141068_0<=Z
MXCQA^T)X4T#X;R^+M.U&'6K:1S;V<5LQW7-QVC QD>IR.!S6;\%/A[J\UR_C
MSQRXO/%VI)F"%U.S2X#R(8U/W21]X]>Q[ULJ=H\T]$>1/'JI5CA\+:4FKM[J
M,>[MNWT77?8]C#9[4ZF@4HK$]<",T4M% SX[T[4]0U6^\)>*=2UNY\+WVH_%
M;4[/4@Y@QY<$%]:V=LYD3A2D$05>[3EA\Q4CC/A5^T3XHL_#GPJ:35M-TK0K
MKP_X>GFTGP]96,3P2W5T\4@>R<(SPR#:J&S?=$4<M&_ /VCI'@+2-%U77KVV
MA.-:NX[^ZMI%5H?M*QK&957;PS!$W'/)0'@DYUVT73GFM96L;9I;7_4.85W0
MYZ[#CY?PQ0!\5^+/C3XO\3>!M1@@\<0WNK:[I?BF'4?#>G:>B7&@"T@N#$R,
MJ^:C(\44+-,2)&N T>WY:V_#7[1>IZ#X;U?26\6:?<W5F/"5OH;W"0&6\BNQ
M;I<.H7 EW$S+N484J>A4U]>1:99P74]U':0QW-P )9DB4/(!T#-C)Q[U$FA:
M8DD,BZ?:J\*&.-A @*+G.%..!GG H%<^4/\ A9GQ+UCQMX7TR/QTFG6OB2X\
M5J!;Z1:R-:1Z9=&.V$9=3EBH_>%]P/\ "$/S5CVG[37BJ^U[P>X\3H5N=2\.
MZ;J-C)!I]K;L;N"U:X"1N[7<K,;G>LB!(E "C?M8G[/%G;AE801Y7=M.P<;O
MO8^O?UJ#^P].^U?:?L%M]HV"/S?(7?M!R%SC.!@8'M0,^4?V</B1K-EK/P\\
M.6/B6U\5Z?J_]MKJ>E6\$2-H26\TABE) \WE]L+>82':8,FU0 >X\;?%3QMX
M<^,P\ VC1W,NLW%KJ^E7 M5;RM,A1CJ,). "P:&-%8Y(-ZG7;BO>[;3+.TN)
MKB&UAAGF $DD<:JSXZ9(&3CMFIS'&91(4'F!2H?'.#C(S^ _*@#X.T?]J_XG
MOX3N-76YL-1N[OP_-J5W:-+93MH4HN(4:18;;,BQ0++*KI=-NW0CD'>HTM#^
M(U]X;^*7BVTL/B59W.EZWXMT[3M0\:M;VK"SB729)53(46P=Y(TA#E=O[T#!
M<5]K6^E65I)<R06D$,ER=T[QQ*IE/JQ ^;\:B70-+CT][%=.M%LG&&MA;H(V
MYSRN,'F@#X-^)7Q8UVX\-:GXCO?%-AJ[Q^$M;AL8;NQM7T_7%MM32);G[.ZD
M/F/:QVG:=FX81L'V(_%;QS9>.;"];Q#'=Z3=?$"7PM_8C6$"QBU%LS@B4 2>
M:' (8MMQP5/6OI632K&985DLX)!"NR,-$I"+C&%XX&.,"I3:6Y(/DQG#^8/D
M'WO7Z^] KGRE\<]<\1:SKMI-?:IJ/PZNI_"6NK#I(N+&X-S)']F?Y6PX8E=Q
MPIW (2, G/%_#[5]3^ DWBJ]TWQ KZ#H%MH%_J&AR6=L@&E/"PNIXHXD0IL+
M,^Y>"4.=Q-?<%Q9VUTT;301RM'DH9$#%<C!QGIQ2&PM&D,AMH3(T?E%S&,E/
M[N<=/;I0,^=M!\0^(;WQG\&/$NJ,D6J^*)M3@N;:&'8%TV2WFNK:-]IP6C$5
MN=S=V?&-V*^DAT%<_-X,T^X\8VOB6;SI=0M+-[*V1F'E0([*TC*N.&;8@))Z
M+@8R<[^:!#J*;NI-U 7'T4W=]:44#%HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH 1NAS7PCJ5WX0L/"_C+4_'&C^%M;^)MMK=TU[%X@UDZ?JT$&__ $06
M$@C>5=R!-@BVJ6+<YR*^[CTKR&+XV>%-:\56ZKX<U>\M5U$Z3#XF&E+)9+=
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MLB##I\<9&.06[;,=_P#IFG_?(]Z;%X"T* Y33HE. ,[FZ8 ]?11^5?)VK_\
M!0F;5M 35O!WA5-3TW4=3TK0-+U&9IYD;4;JT:ZN$>&"-Y6%O&$5DC#.TC;>
M.M3:O^V)XZ\5Z)I&C:!X+M-%\47>@ZMK.J#6[VXLUMX;.4P?Z-NA$A:1L.ID
M5=JD;AUP<S[A[&G_ "K[CZKE\!Z%.VY]/B8D$9W-T(8'OZ.WYTMSX&T.[<O/
M81.V2<EF[ER>_P#TT?\ [ZKXS\"_M<?$#1_A%X?_ +.T73_%EQX:\!V/BWQ/
MJ7B'6'@N;N*42?NX,(VZ7$3,7?Y<X7JP-<[XY_:@\=7EW\8KZ]N;D>%=+O\
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M#7)]4T.?2;][U)+F*&V15GQ<%5<$8(SA2WH*^T@ !C'%%  HP*6BB@ HHHH
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M7U% <R'44W>OJ*#(O]X?G0',AU%-#AAP<TA<#O\ K0.Z'T4T2+_>'YT>8O\
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MEVL_]!&?\Q_A61Z45[5V?D?LX=E]QK_\)=K/_01G_,?X4?\ "7:S_P!!&?\
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MM5FO;OS)\"65YI06DPB*%!/KSS516J,:U1>REH]GT?\ D?D7Z458$5KDYN)
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M-Y;P#Y;>)C[S8]?]GZ?G[<KYMX$'^CQ[L\CSN,<?[/U_(>O#N'(_Z9W>B?\
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M[0:-@QTIU% ";1CI2;0>U.HH 0#'2OCK]L]-!;XO_#4^(KSP/8:?]DU >?\
M$'35OM-#;1@&-I(QO]#NK[&KF_&'B_1/"IT]=7.9;V4PV\2PF5F(4LQP!P
M23VH ^;?@IXP\:>#OV?+>+PKX27Q)9VEM?O%K$=]Y5LSJS-$;6TD7S# W&Q
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M@O\ Y'+P_P#]A*U_]')2>S-:7\2/JCV'XP_\E6\8?]A:Y_\ 1AKCZ[#XP_\
M)5O&'_86N?\ T8:X^NR'PH^/K_QI^K"BBBK, HHHH *#T/THH/0_2@#]#/"'
M_(A^$/\ L!V/_HA:U,5F>$/^1#\(?]@.Q_\ 1"UIU[>'_A1]#\?S[_D:8C_$
MPQ1BBBMSP0HQ110 8HHHH [#0^/#]G_UTE_]"%6ZJ:)_R+]G_P!=)?YBK=>,
M_B?JS]>C_!H_X(?^DH*0C-+1Z4A'<?#'_F(_6/\ ]FKNZX7X9?\ ,1^L?_LU
M=U7S&+_C2_KH?T?PK_R)Z'S_ /2F)BC%+17&?6"8HQ2T4 )BC%+10 F*,4M%
M "8HQ2T4 )2T44 %%%% "44M% "8HQ2T4 )BBEHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ#XNV<B?%[P?=RQ
M!K6XT[4M-@F:7:L=U)%\BD=,OT!->WU\]_M%_%/3O WC3PQH=[:^#;>/6(;B
M9M5\9W?V>VB,(RJ!MIY.3@]N>#03*_V3S#0?V:?&OA)OA9<:/;6<=FNI6UYX
MKTM[N,?9Y83)MNH2#M9B&"N!DMP>2*Z.Z_9RUA/ASX5CMY-7G\06>OPW]UI\
MWB.62SCA%P[LRPM+Y/"L" !WXYKT_P"$VO\ AOQO\);;Q=JOAC3/#MHT4LLX
M&R6V\N,D&9) !NC(7<&(!QVK&L?C/\(_L#S0Z3/!,[1+:V#>'YX[J_$G^K:V
MA,>Z96QD%01@<XJO=,[U>R^]_P"16^!ESK?PT^&/_"-^*O!^I:9#IZWT]QJL
MEW8R6AC,DD@QY=PTG*L/X/K78_LVV4^B?!7PQ:W^()_(>41/*6*(\C,@RW/W
M2.M>1>,OC]X.TJ]4^&_!^DZS8OI37LKW4+6TT4RW:6[P21-'E&7=DAN<@<=Z
MZ3XV_$WPY\'?&O@BSN_ UCJ.EZSY[W^HQ1KOTZ&,+F;;M^9 7&[D8!S1H%ZO
M9?>_\CZ&-S$#CS4S_O"E-S$.LJ#_ ($*^6_%7QY\(>'/'NDV&K^'O#5IHMUK
MD^E-KE[<)'''&D E67<R[?FW8QG'O5[PG\:/"OQ!\<W>E:9X<\/:OI$.O+H\
M&JV<ZSI*I@\TR JI7(/& ?QH]T+U>R^]_P"1]+?:8O\ GHG_ 'T*3[3$1GS$
MQ_O"N.\8Z=X2\&^$M4UK4=&L!I^G6SW,BF!1D*,X''4X 'X5Y]9?$KP'H]II
M&GZ_H4%KJMW:0WEW:Z7I4MW;V$4Q B,\B(5C!RHR?Y<T>Z*]7LOO?^1[D+F(
M_P#+1/\ OH4"YB/25#_P(5X=;_&'X/P2WJBQ6UM(H)[A+Y]$F2UO$ASYQ@E*
M;9MN3D*22#QFLJT_:!^#7VXVL.DW5K>22PQ2"X\-7,"QF<9@>5FB 1)<_*QX
M.:7NCO5[+[W_ )'T-]IBSCS$_P"^A1]IB'_+5/\ OH5\[^"OCK\*=<T3^T]6
MTNWT"XCM9+N22ZTJ:."41R;'\B5HP)B&VC"Y))& <BK^I?$OP/?>'[G6M+\+
MQW+:/>VT6JZ?J>E26EY;02E0LRQR*"1S&P/0J#R,4_="]7LOO?\ D>\FYB'6
M1/\ OH4&YB'61!_P(5A-X(\-ZA#&[:)I\T94%"UNI&,<8X]*?+X$\.W">7+H
MEA(@_A:W4CO[?[1_,T>Z%ZO9?>_\C:^TQ8_UB?\ ?0I1<1'I(A^C"L7_ (0;
MP^8O*_L6P\O.=OD+CO\ XG\Z6'P-X>MQ^ZT6PC'^S H]/;V'Y4>Z%ZO9?>_\
MC8%S$>DJ?]]"C[3$3CS$S_O"L2W\ ^'+60O#H6GQ.?XDMU!/3V_V5_(41^ O
M#<4ID70M/61A@L+=<G@CT]"?SHT"]7LOO?\ D;9N8L_ZU/\ OH5YK^TK/&?@
M)X^ =<G1[CC</[E=>_@+PY)*9'T+3V<YRQMUR<[L]O\ :;\SZUYU^TGX-T)?
M@9XZN!I%D)X](G=)/(7<K ;@0>Q!YIQM=&-9U?92T6SZOMZ'XF[&_NG\J-C?
MW6_*K(U:]4Y%W,"1@D.?\]S^=+_:][OW_:YMWKO.?\]:]L_(]2KM;^Z?RHVM
M_=;\JMMJUZ7#&ZFW#OO.?\\#\J0ZM>MC-U,<>KGV_P !^5 M2KL;^Z?RHV-_
M=;\JM'5[UEVF[F*^F\XH_M>]V%3=S;3U&\X/7_$_G0&I5V-_=;\JV?!:G_A,
MO#^00/[2M><?]-DJBFKWRY NY@/9S]:U?"%_<S>+-#ADGD>*74+9'0L<,IF0
M$$>F!4O8TI\W/'U1ZS\8.?BMXOQS_P 3:Y_]&-7(8/H:['XN2O!\4O%L<;LB
M)JEPJJIP% D( 'Y"N2-S,3DRN3]:[(_"CY"O?VL_5D>#Z&C!]#^52&ZF8Y,S
MGZM_GUH:[GVG]\_3^]5F&I$6 ZD#ZFDW+_>7\Z_6GX'?"_P??_![P7=7/A;1
MI[F72+9Y)9;&-G=C%R22,DG<WYFNY?X2^"I7#/X2T-F!SDZ?%GKG^[[FO->-
MBFURGZ#3X/K5(*?MEJK[,_%W>I_B7\Z"RX/S#IZU^T3_  F\%2%=WA+0SMQM
MSI\7&,$?P_[*_D*#\)_!10(?".AE0, '3XNG'^S[#\JGZ]'^4U_U-K?\_E]S
M/FCPA*G_  @7A#YU_P"0'8_Q#_G@M:?G1_WU_,5]&?\ "N/"HM_('AS2Q#MV
M>6+1 H7!&,8Z89A^)I4^'/A9 X7P[IBA\[@+1.<[L]N^]_\ OH^M=U/-XTX*
M/)MYGQN/\+:^-Q53$_6DN9WMRO\ S/G+SH_[Z_F*/.C_ +Z_F*^C8OASX6@E
M,D?AW2TD)W;EM$!SD'/3U /X4V'X;>%+>42Q>'-+CD&,,MH@/&S';_IFG_?(
M]*T_MJ/\GXG!_P 0CQ'_ $%K_P !?^9\Z>?'_?7_ +Z%'G1C^-?S%?13?#3P
MFS;CX;THG&,_9$Z8QZ>G%+<?#;PI=J5F\.:7*#D$/:(<Y# ]O]M_^^CZT_[:
MC_)^(?\ $(\1_P!!:_\  7_F?.AFC'\:_F*7SD_OK^8KZ,F^'7A:Y4K+X>TR
M1222&M$/)+$]O5V_[Z/K2CX=^%Q&L8\/:8$4@A?LJ8!!4@]/5%_[Y'I1_;4?
MY/Q'_P 0CK_]!:_\!?\ F>0Z)*G_  CUF=ZX\R7^(>HJWYT?]]?^^A7J=O\
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M\#>'ECD0:)8!)-VY1;KALER<\=S++_WVWJ:QT/6O5[+[W_D;0N8CTD0_\"%
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M'>KV7WO_ "-D7,1_Y:)_WT*07,1'$J'_ ($*QHO OAZ&-8X]%L$10 %6W4
M;,=NWEI_WPOI38? /ARWC:.+0M.C1AAE6W4 C!7'3T)'XT>Z%ZO9?>_\C;^T
MQ'/[Q./]H?Y[4?:8LX\Q,_[PK%C\!^'87D=-#L$>3.]EMU!;._.>._F2?]]M
MZFA/ GAV.X\]=#L%FW;O,%NN[.<YSCKGFCW17J]E][_R-K[3%G'F)G_>%!N8
M@.94'_ A6+_P@7ASS5E_L+3_ #%((;[.N1C9CMV\M/\ OA?2DE\!>')T1)-"
MT^1$ "AK=2  % QQZ(O_ 'R/2CW1WJ]E][_R-LW,0&3*@'KN%+]HB _UB?\
M?0K#G\ ^'+F#R)M"T^2'!78]NI&"&!&,>C,/^!'UI\G@?P_+$8GT6P:,YRI@
M7!R6)[?[;_\ ?1]:/="]7LOO?^1L"YB/21#_ ,"% N83TE0_\"%8T7@?P_ N
M(]%L(QG.%@4<Y!]/4 _A26_@/P[:$&#0]/B(QC9;J,8VX[?["?\ ?(]*/=%>
MKV7WO_(VOM,)/^M3_OH45A#X?^&E?>-!TX/C;N%LN<8 QT] !^%%+0=ZO9??
M_P  Z*BBBD;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5Y;\3?@_J/C/QQX<\4Z1KUEI.H:-!<6ZPZCI7V^"59@ V5$L9!&
M..:]2K&UCQ=IF@R&.]DF1@H8B.VEEX/^XI]*:5]B9245>3L>1Z3^R)X-3PH=
M.UN(:SK#QW2G5HX_LGE&X)+^3#&VR-1GA<''J<FLK6/V7M?\2Z)I5CK?CJVU
M9-":W&D6-QH*-IZI$NT?:(3*6E9EP"RN@XX KV6/XBZ'+ 95FNM@];"X!_(I
MFDM_B-H=T"8YKHX];"X7^:>]/E?8S]M2_F7WGB4O[&UO=VL:R>(X+27["]I(
MFF:+#:6^7NDN"R1(W !0+\Q8G.2Q->I>*_A%9>+_ !UX;\0WMSYD&D65Y8R:
M<\(:.ZCN$",&.>  .F#G-;47Q(T*:38D]UN]["X'\XZ1_B3H*3B%I[H2'M_9
M]P1^?EX[4<K[![:E_,OO/(/"/[']AX1UWP_>Q>)[V^MM%UJYU6VMKRW60^7+
M$(UMRY/W4 X.,XP,5JWG[.%W;>*]5\1Z#XHBTW4[S6DUB-;K2A<01$0^48RB
MRQE@1SG<*]+G^(^A6TPBDGN@YZ 6%PP[]Q'CM2W'Q%T.V*^9/<C=TQ87!_E'
M1ROL'MJ?\R^\R/%_@35O&GPHUOPSK.J6UYJE_9RP?;;*U-I%N(^0B-GD*C(&
M?F-<-I7PA\67XMM3L?$<O@Y]3L+6SUS3I+&.ZE)@4)N@FW@1EE&TDJXP<@ U
MZB_Q$T-(A(9KK8>_V"X]NVSW%)%\1=#FM_.6:Y\OKDV-P#^13-'*^P>VI?S+
M[SQA?V1YKJPTO1=0\6BZ\.:!%<QZ#:II@2XM3,,%II?,(F*C(&%7.<G-='XA
M_9LM]?N]9G;7YH/[1.F$J+53Y?V,*!_%SOV\^F>]>AV_Q'T*Y5S'/=$+G.;"
MX'3/JGL:(/B/H5R[K'-=$ID-FPN!Z^L?/0T<K[![:E_,OO/%K_\ 9'N_%&D6
M>D^)_&SZKIVCVTL.B?9M+2VFM9'D63S96WL)2IC0  *" <Y)S5SQ'\%/%,FA
MZX;S4X/$_B3Q,]EIMQ=VUB+.ULK*)@S-Y9E9B<*<G<3N<8  KUU/B/H3S>4L
M]T7SC'V"XQV[^7CO22_$C0H9%1YKH,V,8L+@^GI'_M#_ "#1ROL'MJ?\R^\Z
M&RM5LK2"W3.R)%1<^@&!4U<S<_$?0K15,L]T PR-MA<-VSVCI9_B+H5M%YDD
M]R%]K&X/KV"?[)_R11ROL'MJ7\R^\Z:BN:_X6'H@A\WSKG9G&?L,^>I'39GL
M:(/B'HERN4FN2..MC./3U3W%+E?8/;4OYE]YTM%<Q;?$C0KN0I%/=%AC[UA<
M+UV]S&/[P_R#21_$K099FB6>ZWJ,G.GW '0GJ8\=C3Y7V#VU/^9?>=/7FG[2
MO_) _'W_ &!KC_T"NDD^)&@Q3&)I[K>,Y L+@CC=W\O'\#?IZC/G?[27CO1W
M^!WCFV$UQYTNDSQJ/L4^"2-HYV8'/<G'?I3C%W6AC6K4_9R]Y;/J?BG15T:-
M=$XVQY _Y[)[^_L:7^Q;O?LV1[O^NR?X^U>T?D7,NY1HJ[_8MV'V[(\_]=D]
MO?WH.C78QE8^?^FR>WO[BF+F7<I45>.BW83<4CV_]=D_QH_L2["LVR/ Z_OD
M]_?V- <R[E&MGP7_ ,CEX?\ ^PE:_P#HY*J+HEXX)"1_C,@[X]:U/".FSV_B
MK1)W""**_MG<B12<"5"< ')X/0<U+V9K3E%3B[]3UCXP_P#)5O&'_86N?_1C
M5Q]=G\6X6N/BCXLD0 H^J7#*20#@R$C@].O>N2-G*#C"_P#?:_XUV1^%'R%=
MKVL]>K(:1ONM]#5AK.53@JO_ 'V/\?:D:RFVGA>F/OK_ (U1@FC]B?@'_P D
M3\"_]@:T_P#12UW]>.? GXAZ';_!SP5;O-="6/1[8,!87! *Q'/(3!_U3]/0
M?WAGO+GXCZ%:3+%+-=!V;8 MA<,,Y*]1'CJIY_Q%?,RB^9Z']&8:M3]A#WEL
MNOD=/28KFYOB+H<!B#S70,NT+BPN#U* 9PG'^L3KTR?[IPDGQ&T**!)FGNO+
M=0RD6%P3@A2.!'D<.OZ^AQ/*^QT^VI_S+[SIJ3%<TWQ%T-;=Y_.N?+52Q/V&
MXS@!B>-F>B-^GJ,K'\1-#E$A6:YQ'NW9L9Q]WS,_P<_ZI^G7 Q]Y<G*^P>VI
M?S+[SI,48KF[;XBZ'>7!ABGN3(&VD-8W"C.X+U*8ZD?SZ4VW^)&A74XABFNC
M(=O#6%PH^;R\<F/'_+:/\S_=;"Y7V#VU+^9?>=/17+-\2] 1MIGNLX#?\@^X
MZ$!O^>?H:6\^).@V"L9I[H!0Q.W3[AN@D)Z1GM$_Y#^\N7ROL'MJ7\R^\Z>B
MN;NOB'HEG&7EFN@H)'RV,[="ZGHA[QM^0]1E5^(6B/"LHFN=C,%!^PSYR2@'
M&S/61/S/]TX.5]@]M2_F7WG24F*YFV^(VA7=LMQ%/=&)@I!:PN%/(C(X,>>D
MJ?F?[K8(?B1H4Z,R3W1 7<<V%P.-I;O'Z*?_ -9HY7V#VU/^9?>=/17+GXDZ
M$+B2#S[KS(]VX?V?<8X\W//EX/\ J).G7"_WER]_B)H<=\;1IKD3[]F!8SD9
MW%?O;,=0><^_3FCE?8/;4_YE]YTF*6N8?XC:$D\41FNM\I4*/L%Q@Y,0'/EX
M'^NCZ],G^ZV"7XCZ%#%'(T]ULD4,I%A<$X*HPX$?'$B=?4CJ#@Y7V#VU+^9?
M>=/17,R_$;0X;9KAIKKRE!)(L+@G 5V/ 3/2-OR'J,B_$70WBED$USLC+!C]
MAG_A,@/&SGF&3IUP,?>7)ROL'MJ?\R^\Z6C%<Y:_$+1+T,8IKD[6VG=8SKSN
M5>Z#NP_GT!IEI\2-!O7189[HL^W&ZPN%^]Y>.L8Q_KH_IDY^ZV%ROL'MJ7\R
M^\Z:C%<N/B7H!<)Y]WN*[O\ D'W'3:&_YY^A'\NM+>?$K0;%RLT]T& )^73[
MAN@D)Z1GM$_Y#^\N7ROL'MJ7\R^\Z>C%<W>?$30[!PLTURI+;/EL9VYW,O9#
MW1OT/0C*M\0M$18V,USB0@+BQG/4H!_!QS(G7U/H<'*^P>VI?S+[SH\4M<U#
M\1-#GA65)KG8P5@38W ."(R."F?^6J?F?[K8;;_$G0;J%Y8Y[HHHW$M87"G&
MTMT,>>@/\NM'*^P>VI?S+[SIJ,5S47Q&T*:26-9[HM%NW V%P,8\S/5.?]4_
M3T']Y<B?$;0I+HVZSW/FAMF#87 &=VWKY>.H]:.5]@]M2_F7WG345S'_  L?
M0O.6'S[KS&*@#[!<8YV8Y\O'_+1/S/\ =.$G^).@V\:/)/=!7 (Q87!ZA2.D
M?HZ_KZ'!ROL'MJ7\R^\ZBDQ7,W/Q'T*UMOM$D]T(L%LK87#' #'H(\]$;]/4
M9=+\0]$A@,SS7(0$@XL9R>"X/ 3/_+-OT]1DY7V#VU+^9?>=)BBN<@^(>B7"
M[HYKDC..;&<=P.Z>I%-M?B-H5Z0(I[HYQC=87"]=F.J#_GHGYGT.#E?8/;4O
MYE]YTM%<NGQ+T"23RQ/=[L;O^0?<#C /7R_0BBEROL/VU/\ F7WG4T444C4*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OF;
M]I[XI>(?!/Q/\!:1IT_BY]'U&VOI;VR\$V-O=:A*8T!1@LR-\J\YQS7TS7/:
MEX+T'5/%^D^(KNSCEU[3(IHK*Y,K!HDD $@"@X.0!U!QVQ0!\P^$?VK]:\/>
M%M&AO_\ BJ-1UZYO;G1YM8G2UE&GPXP+DV<,H$^[*[ @P?O%:V[3]J#5XM4\
M3:Q-9QV^F+:Z6UII6NW::>EG).K>87D,;2-R.%5'8\86O5M4_9Q\":C)+-#I
MMWI%U)=RWINM'U.YLI4DE $VQHI%**X W*N%/7&>:+_]G#P#?0*BZ1-9SQM;
MO%>V>H7$-S"\ (B=)5DW*P#,-P.3DYS0!YKX6_:TUWQS!91:!X&M;O49([][
ME+C6GAA3[*VUO+9K?<V_^'<B<]<=:N+^UR#XLTFPG\-+IFEW\4,B7.J:@UO-
M/OC+N;8&+R9O+*E643!R>BD5I:C^R?X7D\6Z/-9RW.F:';6MXD]I:ZK>175S
M-<,#*[3++N<,!A@Q(.:Z^3]G;P-)JUG>C3;F.*V$6W3H]1N%L9&B7;$[VP?R
MW95X!*GWS0!Y7I7[:9O(IYIO!ER89[9I]--K<2ON?S1&D-TSP)' [E@1M:08
MSSD5<N/BGX^N]9\0:'JMM%X;U235=.LK2"TNA=QPQ-#YLTB2B-200I!WJ,9K
MO[+]F;P!9QWD)TR\NK2X@>U2TO-5NIX+6)FW,ENCR$0@MS\F""!@C%6_#7P!
M\%>#M375;2TO)K]6:1[O4M2N+R1V,8CW,TSL<A  #Q@4 >577[7FLV-KI"W7
M@FSTZ_UB.>[L+:\UJ5M]I$2OF2-%:R%'=AA4P1W9EKFW_:4\;7/Q NM>L]'N
M+K0_[+T\:;X7GOA9,]S=.5+7!>V+#:5X.1QSM.:^@=:^"?A#Q+I&DV@@O+&'
M38WCLKC2-3N+2>.)_OQB:*17*-W4DBEA^"7@2"ZB*Z+&+A$MU7-S*6VP$F'J
M_.TD\]\\YH \RUS]K&X\*^/;+P[K'A_3$#WT>FW8L-<-U<P2M$TA?RU@V!!M
M(P\B2'@[!6?XJ_:(^(>H?#BS\3>'_!^GZ9INJ7%J=/U&ZUA96,+W C*S1>5E
M'9>1M\Q0#]X$5ZG/^SSX'N?$T^NRZ;<O<37O]IM:_P!HW M/M>"#<?9P_E^8
M02"VWG)JA;?LS?#F#[7;#2[B02Q".&&75+EOL47F>8%M09/]'7>-W[O;S[<4
M <O=_M-ZMID:ZK=^"L>%[BZNM/M+^'55:XEN(8G?+0&,!8G,;@-O+#@E!G%4
M-/\ VK]5LM$M]2\4^"(M#&JZ5_:6B06NL?:FO&,@06[DPH$DRZ'Y=X ;VKT!
M?V;/ /\ :SWTFEW-QEI95LY]2N7M8Y95*RS) 9-BR.I(+@ \GH2:H^*_@7%X
M@\3_  ^BA&GVG@_PBYNH;(I))<M.J[(T#EMHB Y((+$@<C% %SQS\5];T#5O
M#?A_1/#$6K^*-8M)KW['=ZE]DMX(XE4N#-Y;DMN8*!LQU)(%>1^&OVE/&>D>
M//&A\0Z(EQX7M?$5AI.QK^-;K2VN($/EHD<96=1(V2QD'WN.F*]X\<_"WPS\
M45LI=52X-Q9^8D%[IE_-:3QJX DC$L+JVU@ &7.#6=:?L_?#S2-*O+&V\.06
MMC<WEOJ$T23RJIG@51#)]_C:%' P#CD&@#S?P?\ M/>*_'@TR'2?A_8KJ&KM
M<RZ=!=^("BFV@.UY9F%N?+)8@*BA^N21BFV7[6>K:]9#4]&\""?2+6PMK_49
M[S6!!+")93$T<:")A(Z$$\E01CD'BO0=4^"/P_ETG1=#6"72%L&E?36T[59[
M2ZC\PYE"2I()"K=QDC\A6GI7P;\"Z9I-UI5AHT$=C);16$T$<\F#%$=R(?FR
M"#SGJ>Y- '#1_'/7;K4AHGAGPV/$>N2W.H2F'4M56TCBMX)=BX=83EG/RJI7
MC'S/W/M&D75Q?Z9:W-W9OI]S+&KR6KRK(8F(Y7<I*G'3(.*X3Q!\#O WB6RA
M:6UGM422>1;K3=4N+61A<$>>ADCD!*2$#*YQZ 5W6DZ98>'-(M[&Q@CLM/M(
MA'%$G"1HHP!] * +N/K^=>:_M*Y'P#\?8)'_ !)KGO\ [!KT:WNHKR%)H)$F
MB<95XV#*1[$<&O.?VE?^2!^/O^P/<_\ H%..Z,:W\.7HS\,P.G HX]!1Z45[
MA^/7# ]!1QZ"BB@+A@>@HP/0444!<,#T'Y5L>"_^1R\/\#_D)VO_ *.2L>MG
MP7_R.7A__L)6O_HY*3V9I2^./JCV'XP_\E7\8?\ 86N?_1C5Q^!78?&'_DJW
MC#_L+7/_ *,-<?79#X4?'XA_OI^K#%(P^5N.QI:1ONM]#5&"/V0^ ?/P3\"Y
M)_Y MIW_ .F2UWN/K7!_ +_DB?@7_L"VG_HI:[ZOEY?$S^D<-_ AZ+\AN/K1
MCZTZBI.D;CGO1CZTZB@!N/\ .:,>YIU% #0.?_KT8_SFG44 -(^M&/K^=.HH
M ;CZ_G1CZ_G3J* $Q]?SI,?7\Z=10 W'^<T;?>G44 -Q]:-O'4_G3J* &X^M
M&/K^=.HH ;@T$?7\Z=10 W'U_.C&/7\Z=10 W'UHQBG44 -V_P"<T8_SFG44
M -Q[FC'^<TZB@!N/\YI<?6EHH ;BC&.YIU% #2/<T4ZB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M20RM&WWUW@9 89!]B:U[71K*STJ+38K:,6$<0A6W* IL P%QTQB@#YB_8/\
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M%'N=W]W_  0YL5_)'_P)_P#R)WGG)_?7\Q1YR?WU_,5P?_"A_A[_ -"=H_\
MX"K0/@/\/?\ H3=(_P# 5:=H=W]W_!#FQ7\D?_ G_P#(G>><G]]?S%'G)_?7
M\Q7!_P#"A_A[_P!";H__ ("BC_A0_P /?^A-T?\ \!12]SN_N_X(<V*_DC_X
M$_\ Y$[SSD_OK^8H\Y/[Z_F*X/\ X4/\/?\ H3='_P# 44?\*'^'O_0FZ/\
M^ HH]SN_N_X(<V*_DC_X$_\ Y$[SSD_OK^8H\Y/[Z_F*X/\ X4/\/?\ H3='
M_P# 44?\*(^'G_0G:/\ ^ HH]SN_N_X(<V*_DC_X$_\ Y$[SSD_OK^8H\Y/[
MZ_F*X3_A0_P]_P"A.T?_ ,!5I/\ A0_P]_Z$[1__  %%.T.[^[_@AS8K^2/_
M ($__D3O/.3^^OYBCSD_OK^8K@Q\!_A[_P!";H__ ("BC_A0_P /?^A-T?\
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M (0#PY_T!;+_ +\BC_A /#G_ $!;+_OR*O\ L5_S_@<7_$7:7_0&_P#P-?\
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MH]SN_N_X(<V*_DC_ .!/_P"1.[\Y/[Z_F*/.3^^OYBN$_P"%#_#W_H3M'_\
M 5:3_A0_P]_Z$W1__ 446AW?W?\ !#FQ7\D?_ G_ /(G>><G]]?S%'G)_?7\
MQ7!_\*'^'O\ T)NC_P#@**/^%#_#W_H3='_\!11[G=_=_P $.;%?R1_\"?\
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M31?&(L_"-YXPT[3KC2=.CPU\\CR;C+<!N8@J@>4!@DDL> *Q[_\ :Y\4:/\
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M4>PLRPQG9$ P/#,>2/2@#@_!G[(-Q\-)K.^\,>.;A-6L[J_>WNM8L!>J+>Y
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M;:B][J,.JW\VI:+'/>RSJ@#^7+Y@CC5V ;'E$KT5A7T710!Q_P )?AZOPL\
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M!U./X/\ =_,^G(/@KXEV#_2-*#Y&1YLF ,COL]-WY#UXC^T,+_.=/^HG$?\
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MP..$&:]#^%?PUC^&&DZK8Q7[:@M_JESJ9=XA&4,K E, G(&.O>NUHH ****
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M6Y*.TJ/ 2WR$?(, <'%2WWQ4\7:!X]UCPKXG^(>NZ#X.TZYNEA\2FWA^TRW
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MS:7-?*\6]FEL)F,L!4_*"V ^#C[IH]I(/J='L_O?^9ZW_P ('K/_ $/FO?\
M?NT_^,4?\('K/_0^:]_W[M/_ (Q7:8HQ1[20?4Z/9_>_\SF-&\*:GI>H)<7'
MBO5M5B4'-M=);B-O<[(E;CZUTS#(I<48J&W)W9T4Z<:2Y8_Y_F<C>>"M6NKN
M::/QKK=K'(Y988H[4I&/[HW0DX'N2:A_X0/6?^A\U[_OW:?_ !BNTQ1BKYY&
M#PE)N]G][_S.+_X0/6?^A\U[_OW:?_&*/^$#UG_H?->_[]VG_P 8KM,48H]I
M(7U.CV?WO_,XO_A ]9_Z'S7O^_=I_P#&*/\ A ]9_P"A\U[_ +]VG_QBNTQ7
MG/Q?\6^(=)F\->'O"ALK;6_$5ZUHFHZA$9H;&-(GEDE,09?-8*A"IN4$D9.,
MT>TD'U.CV?WO_,TO^$#UG_H?->_[]VG_ ,8H_P"$#UG_ *'S7O\ OW9__&*\
MN\9:C\8O#&A:5H5QXI\.Q:OJ6MVUA9>)X-':3S('!+^=9-*%5U(P"LI!!S@$
M<K;?'/Q)X#F\6>%?%0L/$OBK2([,Z7=:5;FS756NA((T:!I'\ME:)BQ#E=O/
M&#1[20?4Z/9_>_\ ,]0_X0/6?^A\U[_OW:?_ !BC_A ]9_Z'S7O^_=I_\8KQ
MNU^+_P 1_%7AGPZFDWOA[3=8CT*XU[6+NXLI+B"4PS>7]GA02*55CGYRQ( Z
M9->X_##QK'\1_AYX<\41P&V75]/@O?(;DQ[T#%?P)-'M)!]3H]G][_S*7_"!
MZS_T/FO?]^[3_P",4?\ "!ZS_P!#YKW_ '[M/_C%=IBC%'M)!]3H]G][_P S
MB_\ A ]9_P"A\U[_ +]VG_QBC_A ]9_Z'S7O^_=I_P#&*[3%&*/:2#ZG1[/[
MW_F<7_P@>L_]#YKW_?NT_P#C%'_"!ZS_ -#YKW_?NT_^,5VAZ<#FOGKPIXU^
M*7Q5^T^+_"FJ>';30;35+C3X?#.HV$GF7D<,IBD=[Q9"8G)5BH6-E'&<YX/:
M2#ZG1[/[W_F>H_\ "!ZS_P!#YKW_ '[M/_C%'_"!ZS_T/FO?]^[3_P",5S%G
M^TGX?FURRM+G3=3T_2;[4)=)L_$%TD2V-Q=QYW1J1(9 ,AE#LBJ2I&:H_%?]
MHRQ\+Z=JEIX6M+GQ7K-OI4FIM)HRPW,-I$#M$DF95W L<;4W,>>*/:2#ZG1[
M/[W_ )G:_P#"!ZS_ -#YKW_?NT_^,4?\('K/_0^:]_W[M/\ XQ7F>E_M?^%(
MKZPTB^$]Q?*+2UOKR"2V2**\FB5Q$(GF$S<L,E8RHW#)K6UK]K7P1H6A0:K<
M)J7DRVCW;1^0BO%MG\@1R;G 5S)\H!..Y('-'M)!]3H]G][_ ,SMO^$#UG_H
M?->_[]VG_P 8H_X0/6?^A\U[_OW:?_&*\CF_:VTW5O$7A\Z<WV/2[>[OK?Q!
M;3+%=30^3:F9/+D@DDC;..J,V>G%;.K?M<Z'X?T\3:GX/\6V5[.+1['3GLH&
MFOH[EPD3QD3;!\Q&Y7967/(H]I(/J='L_O?^9Z'_ ,('K/\ T/FO?]^[3_XQ
M1_P@>L_]#YKW_?NT_P#C%<+=_M5:-:2I8GPKXEDUT37<,^CI!;^=;&VC$DI=
MS.(R AW JS;N@YXJE+^V-X6M-*BOK[0-?TM;R*WGTV+4([:!K])FVH4+3A8^
M>OFE,=:/:2#ZG1[/[W_F>C_\('K/_0^:]_W[M/\ XQ2?\('K/_0^:]_W[M/_
M (Q7GEI^V!X9UBVLO[%\/Z_KM]/'=R2V>GQVSFV%MCSP\IG$1(!!&QVW9XR>
M*W/A9\;+KXE?$GQ7HL>D-::)IME87EE>R;1),+B,N0ZB0X(QP-HZ'-'M)!]3
MH]G][_S.^\/>'K[1GF:[\0ZAK0< *MZL($?N/+C7]<UY]\;OB';^"+[2K>/4
MO%4^L7X<6N@^$]/AO+JX5.7DVR(<*HZDL![$UZ_7B_[0G@F_\6W.@RQ^!%\:
M6-J\C.VFZN=*U>QD(^62WG\R,;>S*7&>.&Z5/,[W-O80Y/9]/5_GN6?!NI6_
MCGPM8Z_I_P 2=>ALKMS$J7T%I;2I*#AHF1X 0X.05JGHNNS>(?%6JZ#8>+O&
M5Q<Z7??8+R9;*S\F%_+W@EO*^Z0<9QUKR*X^"/Q$NX+:^\5^$E^(WFZ)=:79
M:=J^K6]Q<Z1(\A:*2::3:DC!3AI8\N,#&[K4FE_LV_$""^U%"D-M)/-)Y6I+
M=HQ7-@(1)_>^^,=,XYQ5>TD8_4Z/9_>_\SVZP#ZIXMN/#MK\0M?N+Z"U%W(T
M<=DT07?LV[A#]X'J*M:!8OXG?4$TWXDZW=-873V5P!': I*GWEY@YQGJ.*X/
M]GKX6ZGX.\<SZE<?#VR\$6@\/VVF2RVUW;R-?74;Y>4I"2 #U#-ACGD USUU
M\*O%_AGQQ?ZYI'@&.\CCUK5)%6QO;.W>\@NX55)OF9<;&!#*YW<Y4&CVD@^I
MT>S^]_YGM<WAB]MGA27XC:O$\QVQJ_V(%SZ#,//X5$="G%FMV?B9J@M6?RQ.
M7L=A;.,!O)QG/&*^9?!W[(WB"3PE?P>*/"6E7FJ?V!86-HTTT,S0S)<F254?
MJF%)^88STJ[>?LV^)- ^).MZHOP^T_Q7X+DFNELO#2W5M%"C2PJHN%BD81K\
MP*L?OCJ :/:2#ZG1[/[W_F?2<WA:^MY%27XBZQ$[*7"O]B!*@9)P8>@]:=9^
M$-1U&V2XM?B'K5S XRDL(LW5A[$0X-?.NE?LLZU'HWC-M<\+VNKZG=:/IMCI
M\MMJ4<=R/*4>;%%/(C;0I P'78^W#<&O9?V:/!.O>!?">IV.N:1;:2KZA)+:
M(EM:6]S+$0/GN$LS]G\PGJ8\ ]P#1[20?4Z/9_>_\SK/^$#UG_H?->_[]VG_
M ,8H_P"$#UG_ *'S7O\ OW:?_&*[3%&*/:2#ZG1[/[W_ )G%_P#"!ZS_ -#Y
MKW_?NT_^,4?\('K/_0^:]_W[M/\ XQ7:8HQ1[20?4Z/9_>_\SB_^$#UG_H?-
M>_[]VG_QBC_A ]9_Z'S7O^_=I_\ &*[3%&*/:2#ZG1[/[W_F<7_P@>L_]#YK
MW_?NT_\ C%'_  @>L_\ 0^:]_P!^[3_XQ7:8HQ1[20?4Z/9_>_\ ,XO_ (0/
M6?\ H?->_P"_=I_\8H_X0/6?^A\U[_OW:?\ QBNTQ1BCVD@^IT>S^]_YG%_\
M('K/_0^:]_W[M/\ XQ7GW[0/@_5-/^"?C:YG\8:QJ$,6DSNUK<1VPCE 7[K;
M8@V#[$'WKW7%>:?M*C_BP?C[_L#W/_H%.-25T8UL)15.3L]GU?\ F?B-_:]M
M_P! BR_.3_XJC^U[;_H$67YR?_%5F45[-S\GY(_TV:?]KVW_ $"++\Y/_BJ/
M[7MO^@19?G)_\56910+DC_39I_VO;?\ 0(LOSD_^*H_M>V_Z!%E^<G_Q59E%
M%PY(_P!-FG_:]M_T"++\Y/\ XJM;PCJD$OBS0T72[6)FU"V42(7W*3,@R,MC
M(Z\URU;/@O\ Y'+P_P#]A*U_]')2;T-:=.+G%>?=GLOQ5D6V^)GBJ*2-;J2/
M4[A6GESOD(D/S';@9/L!7*?:X_\ GSA_-O\ &NG^,/\ R5;QA_V%KG_T8U<?
M77'6*/D*\4JLO5EG[7'_ ,^</YM_C1]KC_Y\X?S;_&JU%48\J+/VN/\ Y\X?
MS;_&C[7'_P ^</YM_C5:B@.5%G[7'_SYP_FW^-!NX\'_ $.'IZM_C5:@]#]*
M Y4?>OA71+N3P5X5D77;^)7T>S=8E2$K&#"N%&4S@=!DD^YK2_L*]_Z#^H?]
M\0__ !%3>$/^1#\(?]@.Q_\ 1"UIU[5!)THOR/R7/*DH9E7BNDF8_P#85[_T
M']0_[XA_^(I#H5[_ -!_4/\ OW#_ /$5LT'I6_*CP_:S_I(])^%G@W5;OPI'
M)%XRUJT4S2#RXH[7;U]X2:[#_A ]9_Z'S7O^_=I_\8J/X/#_ (HV/_KO)_.N
MXQ7P6*G)5YKS9_;_  SAJ<\EPDI)W=./5]EYG%_\('K/_0^:]_W[M/\ XQ1_
MP@>L_P#0^:]_W[M/_C%=IBC%<OM)'TWU.CV?WO\ S.+_ .$#UG_H?->_[]VG
M_P 8H_X0/6?^A\U[_OW:?_&*[3%&*/:2#ZG1[/[W_F<7_P ('K/_ $/FO?\
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MCXEV.AW'A^\TA;JTFA;P4W_$B@S&P,4*#A)N-TFTD'*=".0#Z=HHHH ****
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M>AK:\ _!C2_AUXDOM8TW4;^5KVPM;":WN3&T;"W4K'(,(&#;20><'TKT&B@
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M*** "BBB@ HHHH **** "BBB@ HHHH *:RAA@@$>].HH 9'$D*!(U5%'15&
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M)4X;K0![C?\ [0^E6?B?1]%C\%^*+V[UN'[7I\MOI\!CNHUC5RX8S C:K?Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"+Q!9N?&,9FT  M_Q,$$0F)CX_YYD-SC@T7CV#V=?_GXO_ ?^"+_ ,+0M?\
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MO3@/847CV#V=?_GXO_ ?^"<;_P +0M?^@%XD_P#!-/\ X4?\+0M?^@%XD_\
M!-/_ (5V6/\ 9%&/]D47CV#V=?\ Y^+_ ,!_X)S>C>.H-;OTM(]*UJU9@3YM
MYILL,8QZLPP*Z4G I-H/:EQGBH;3V1T04TK3=WZ6.2O/B/;6=U- VB^()&B<
MH7ATF9T;'=6 P1[U#_PM"U_Z 7B3_P $T_\ A79;1Z48_P!D5=X]CG=.O?\
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M=<BPA-S=)*QMWAA'65DE"ML_VL8]Z+Q[![.O_P _%_X#_P $T?\ A:%K_P!
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MK_T O$G_ ()I_P#"NRQ_LBC'^R*+Q[![.O\ \_%_X#_P3C?^%H6O_0"\2?\
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MB5^SMH_C#P^-.T>#1]*8W$5Q*-0TO[=#*8T$:97S(W4JH !213V.1Q6EX$^
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M3_T$-._\"/\ ZU9>31DU[.A^2M2[FG_8)_Z"&G?^!'_UJ7^P3_T$-._\"/\
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MBCGBC"VHGD4B2:&)E5A&2#P?F.2"R;QQH&N?M166E:9X1TR\UFST2^@;QC/
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M_P!FKPU?>#)O#_AFRTKPW'/=1W<_G:5'?0W#(,*)4<AR .A1T9<<$#BO8**
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MA]:A_++_ ,!E_D==17(_VIXW_P"A=T;_ ,'$G_R/1_:GC?\ Z%W1O_!Q)_\
M(]'(^Z^\/K4/Y9?^ R_R.NHKD?[4\;_]"[HW_@XD_P#D>C^U/&__ $+NC?\
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M*Y'^U/&__0NZ-_X.)/\ Y'I/[4\;_P#0NZ-_X.)/_D>CD?=?>@^M0_EE_P"
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MKD?[4\;_ /0NZ-_X.)/_ )'H_M3QO_T+NC?^#B3_ .1Z.1]U]X?6H?RR_P#
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M\^H:C=PQ"-;B\N)6FG<  <;W(&>=H7- '8T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 A&: ,4M% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 GI7FG[2O_) _'W_ &![G_T"O3*\S_:6_P"2!^/O^P-<_P#H
M%./Q(QK?PY>C/PS]**/2BO</QT**** "BBB@ K9\%_\ (Y>'_P#L)6O_ *.2
ML:MGP7_R.7A__L)6O_HY*3V9K2_B1]4>P_&'_DJWC#_L+7/_ *,-<?78?&'_
M )*MXP_["US_ .C&KCZ[(?"CX^O_ !9^K"D;[K?0TM(WW6^AJC!;G[(_ +_D
MB?@7_L"VG_HI:[ZN ^ ?_)$_ O\ V!K3_P!%+7?U\O+XF?TCAOX$/1?D%%%%
M2=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'RNWQ<\: G_ (J*7_P$MO\ XU2?
M\+<\:_\ 0Q2_^ EM_P#&J**];DAV/RKZ[BO^?LOO?^8?\+<\:_\ 0Q2_^ EM
M_P#&J/\ A;GC7_H8I?\ P$MO_C5%%')'L'UW%?\ /V7WO_,/^%N>-?\ H8I?
M_ 2V_P#C5'_"W/&O_0Q2_P#@);?_ !JBBCDCV#Z[BO\ G[+[W_F'_"W/&O\
MT,4O_@);?_&J/^%N>-?^ABE_\!+;_P"-444<D>P?7<5_S]E][_S#_A;GC7_H
M8I?_  $MO_C5'_"W/&O_ $,4O_@);?\ QJBBCDCV#Z[BO^?LOO?^8?\ "W/&
MO_0Q2_\ @);?_&J/^%N>-?\ H8I?_ 2V_P#C5%%')'L'UW%?\_9?>_\ ,/\
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MO_,/^%N>-?\ H8I?_ 2V_P#C5'_"W/&O_0Q2_P#@);?_ !JBBCDCV#Z[BO\
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'7--O7NS_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tmb-20220511xex99d1021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  V '$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBH;FX%K!)*RNZHNXK&A=C] .2?84 34F:JV&J6NJ1&2UG290<';U4^A'4'ZU
M@:SK]QX3U9+C4I/,T*[D6(7!4#[%(>%WD?\ +-C@;CRK'G@\ '544BMFEH *
M*** "BBB@ HHHH **** "BBB@ HHHH SK_0[>^E$^&M[L#"W,#;)!^/<>QR/
M:L74UO&M[G3-;L$U71YX?+DNX@"6#<$20^@'.Y2>OW1BNKI",T >2?"_QAK%
MDM[X<OTCUF727Q!<6\W^DW-D21%-L8X;&-A(?.5R1DXKU/3[Z/4;5)XA(J./
MNRQM&X]058 @UP/CGP?#>>+=&O=,G;1]<9)A#>P*,,P ?;(N/F5@I!'!P>O2
MK^@?$-U*V7B:T71M31_*D=26M2Y^Z%D(&-PY&X#/0'((H [BBD!S2T %%%%
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M' ]:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tmb-20220511xex99d1019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  R (X# 2(  A$! Q$!_\0
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0 ****& 4444P"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tmb-20220511xex99d1006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &5 Z@# 2(  A$! Q$!_\0
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M#>"KN2PC80P1,T+PHB?:C(2JL6<^6P<A0., 'Z"R:A;0W45M)<1)<2@F.)G
M=P.N!U./:JM_XDTG2KE+>]U.SM+AP"L4]PB.V3@8!()K\Z_@M\2-4^)O[37P
M,U?7OB3!XUUZZT74[B^TA+*VMVT.9@H:V(A56^4@C$F6^4G."*E_;<CT*X_:
MHN;?7+_X8V$<W@N".*7XF6\TT*L;BX^:V\L@B0<'//;B@#]( P(R.:.M?FOX
M4_:$^(7PA^ OPNN-#341I'B;PQ+X>T.ROK=+AXM>2X6.WN/,* F&6-RZ*W&V
M+[O7/Z*>%;74+'PWI=OJU\VIZG%;1I=7KQK&9Y0HWN54!1DY.  * -6BBB@
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M(.&4D'!!'X5^:WP_^(?B#QSXC^"7B+QCX[U&%K/7=;T>.Z\R-DN=L.;>*1S
MGF-(#LWE$+JV<#-:<OQN\2:)X(\$VNO^/;[X5^&9]+U6\MM7T;3H$%_JD=[*
M(K5OW#*@V@'8 #)SR>: /T@W#UI=PSC-?FSXI^.'QJUW3=<O=0\5:SX.U/1?
MAM;^*3IVGVD,:2WPF*@R*\;,%==K,BD=<<"M$?M+^.;?XY>$_P"TO%VI:C#J
M:Z5M\.Z))';SQ">!6EWV$]I_I,1<D^?%,-@X'2@#]%0<TM-4Y'I3J "BBB@
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M,EM%]H\A&(0/NWQ+B3<, XZ#D ^\-P/>C<,9R,5^</AG]I+QR_PL\7:_X?\
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M "D* ]LTZB@!NP9Z4I44M% #=H[C- 0 YQSZTZB@ HHHH **** "BBB@ I"
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MM%OHC+:*.K2KNR@]VQ7A&J?L\:Q%XR@O])TK2K.P6+1%=872++6ID\WY57G
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M2*OE\SD]O+_GW+\/\ST"BO/_ /A'/B)_T.FC_P#A/M_\D4?\(Y\1?^ATT?\
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M_0Z:/_X3[?\ R11_PC?Q%_Z'31__  GV_P#DBGR^:(]O+_GW+\/\ST"BO/\
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MB_\ 0Z:/_P"$^W_R11R^8>WE_P ^Y?A_F>@45Y__ ,(Y\1?^ATT?_P )]O\
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MBC!3AB#@D9YJ3I' TM>?_P#"-_$3_H=-'_\ "?;_ .2*/^$<^(O_ $.FC_\
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MW?\ !/::0FO%_P"V/B#_ -#1I/\ X(S_ /'ZZ'3](^(FH6<=P/&6CH'&<?V
M3C_R8HY+=4=.'S6EBI.-*$FUY+_,]'(W#%-\L8Q@8],5P7_".?$7_H=-'_\
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ML[9GN=-O[*!TDN$>1<[)9/+=D'W@"#V(DU#]GG]H'4_B?X8\<:CKWPWU^_\
M#VDQV6FV.JVM[]DLKHJ!/>11Q;!YLFW@G[@.% P#0!V_QG_;'@^!MU\/++Q#
MX2NO[0U^&.[UV&"Z61?#ML7BCDFE<*1(J2S*F1@,0>>E>E:-\88-9^..O?#B
M/3F672M%M=9.I"<,DJS2R1A F,C'EYSGG->$>*OV&]4^-?C#QEXI^)GC.[MM
M4UG2;;1;6T\'WDUK9PVJ1[I8Y4<$RHUP6D"DXP!WIOA/]GWX]?#SQC8>)]$\
M1^ M4U<^%+'PWJ,NNPWTGGFUDD*SKY94Y973=N)Y#4 :_B_]L3Q-I_QF\;^
MO#/P\TK6CX6DM(Y[[5/%]MI1F,\ E79'*F6QD@X)Z#UJ]\3?VR;CX1>*YO"W
MB+P%>CQ%J%I:S>%[2QN_/CUR>5ECEMED"!8WBD?G.04^?OBN%\1?L??$"_\
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M>"=.U+PRL%^M[INL7-_8O<Q1S&:VNK4(7MVMA&9?,^8Y7:" I)&.:]&B\?\
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MBT4451\^%%%% !1110 5ZKH/_(HZ+_USE_\ 1K5Y57JN@_\ (HZ+_P!<Y?\
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M>S@KM+$8 "D<$&@#4OOVAXK+PWI.K?V%*ZZA/J\(B^T@&/["+DDD[>?,^S'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLS;460H0OFC(.* /N':N*C22*1W575F0X8!@2I]#Z5\,^(_CWXZA\/036_Q
MCDTS3M3U&WBU&WN-/L[_ %BU@$)2Y3[3%]GN50O(KI&T9?9D'@U%>?&+Q&$\
M57NC>(;'0FO->L_-D5;+1[^^1M+CFVK+/')"DVX@E9CDJ"BOG% 'VY#X@TJ?
M6YM'BO[=]4@C662S$@\U$.<,5ZX.#6EY8KSKX(WFG>-?!.B>-1;FYUG4K(0S
MZO>6$5M>7"([##^62NW*Y&TE#]Y>"*](H ;Y:^E&P4ZB@!NP4>6OI3J* &[!
M1L%.HH ;Y8HV#TIU% #=@]*^!?\ @I N/&OA'_KPD_\ 0S7WY7P)_P %(?\
MD=O"/_7A)_Z&:N&Y\YQ#_P B^?R_,^/*,"BBMS\=# ]*,444 &*,444"#%>X
M^"!CX-:3_P!A>\_]!CKPZO<?!/\ R1O2?^PO>?\ H,=4MS'$_P"Z5O3]4.Q1
M116A\ %%%% !1BBB@ Q7LGAP ?##PS_UWO\ _P!'+7C=>R>'/^28>&?^N]__
M .CEH1UTOX%?_"O_ $N(M%%%4?/A1110 4444 %>J:" ?".B_P#7.7_T:U>5
MUZKH/_(HZ+_USE_]&M4RV/K.'OXM7_#_ .W(L8'I1@4M%9'UPF!Z48'I2T4
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M[4F=&'B.^55/*B&##<DX/R>X'_ 1[TJ^'M1$P<^([YE'_+,PPX/W?]C/8_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]#-7#<^<XA_Y%\_E^9\>4445T'XZ%%%% !1110 5[CX)_P"2-Z3_ -A>\_\
M08Z\.KW'P3_R1O2?^PO>?^@QTUN88G_=*W^']4.HHHK0^ "BBB@ HHHH *]D
M\.?\DP\,_P#7>_\ _1RUXW7LGAS_ ))AX9_Z[W__ *.6FCKI?P*_^%?^EQ%H
MHHJCY\**** "BBB@ KU70?\ D4=%_P"N<O\ Z-:O*J]5T'_D4=%_ZYR_^C6J
M9;'UG#W\6K_A_P#;D6:***Q/K@KU?X7?\BY)_P!=V_D*\HKU?X7?\BY)_P!=
MV_D*SGL?7<,?[\_\+_0[&BBBL#]8"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** //3\>/!JD@WU^"./^0->_P#QFD_X7UX,/_+_ '__ ()K
MW_XS747/C+P_9Z=J6H3ZYI\-AILI@O;J2\C6*UD&,I*Y;",-R\,0?F'J*U+6
MY@O;:*XMYEG@E021RQN&5U(R&!'!!'.15WAV_'_@''R8K^>/_@+_ /DC@_\
MA?7@S_G^O_\ P37O_P 9H_X7UX,_Y_K_ /\ !->__&:[J]O;;3;.>[N[B.UM
M8$:66>:0(D:*,EF8G   ))--L-0M-5L;>]LKJ*\L[B-98;BWE$D<J,,JRL"0
M01R".#3O#M^/_ %R8K^>/_@+_P#DCA_^%]>#/^?Z_P#_  37O_QFC_A?7@S_
M )_K_P#\$U[_ /&:] X]3^=(SHH!+8!.!EL9/I1>';\?^ ')BOYX_P#@+_\
MDS@/^%]>#/\ G^O_ /P37O\ \9H_X7UX,_Y_K_\ \$U[_P#&:]! ![G\Z-ON
M?SHO#M^/_ #DQ7\\?_ 7_P#)GGW_  OKP9_S_7__ ()KW_XS1_POKP9_S_7_
M /X)KW_XS7H.WW/YT;?<_G1>';\?^ ')BOYX_P#@+_\ DSS[_A?7@S_G^O\
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MW/YT7AV_'_@!R8K^>/\ X"__ )(\^_X7UX,_Y_K_ /\ !->__&:/^%]>#/\
MG^O_ /P37O\ \9KT';[G\Z"N.Y_.B\.WX_\  #DQ7\\?_ 7_ /)'GW_"^O!G
M_/\ 7_\ X)KW_P",T?\ "^O!G_/]?_\ @FO?_C-=_N7=MW?-UQGFG;?<_G1>
M';\?^ ')BOYX_P#@+_\ DSS[_A?7@S_G^O\ _P $U[_\9H_X7UX,_P"?Z_\
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M"3]HGQ7XE^).BIXEU*UAT77;AK:Q@TFUM[NR=_LRRB$S)-]H@G4D[A+&4(P
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MW5]#NVGTZ73H+66VM8[596FD\LW<UPOE2(!O6/;C&?NG[=S[49]J /DCX/\
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MV,_95O\ GZ_N1R/_  L36O\ HGWB/_ONS_\ C]'_  L36O\ HGWB/_ONS_\
MC]=SN'I^E&X>GYBCFCV#V5;_ )^O[D<-_P +$UK_ *)]XC_[[L__ (_1_P +
M$UK_ *)]XC_[[L__ (_53Q[^T#X%^&.LPZ7XEU2[T^]F*K$J:3>3I(S#*JKQ
M1,K,<'Y0<\=*Z#PK\1O#WC6YN+?1[XW-S;1133P26\L,D22KNC+)(JE<CG!&
M?6CFCV#V5;_GZ_N1E?\ "Q-:_P"B?>(_^^[/_P"/T?\ "Q-:_P"B?>(_^^[/
M_P"/UW.X>E)O'H?RHYH]@]E6_P"?K^Y'#_\ "Q-:_P"B?>(_^^[/_P"/T?\
M"Q-:_P"B?>(_^^[/_P"/UW.X9Z'\J-PST_2CFCV#V5;_ )^O[D<-_P +$UK_
M *)]XC_[[L__ (_1_P +$UK_ *)]XC_[[L__ (_77ZIJMGHNGW%]?SQVEG A
M>6>4[411W)[4RPUJSU22Y2UD,K6Y59#Y; 990PP2,,,$<C-'-'L'LJW_ #]?
MW(Y/_A8FM?\ 1/O$?_?=G_\ 'Z/^%B:U_P!$^\1_]]V?_P ?KN-P]/TI2P'8
M_E1S1[![*M_S]?W(X;_A8FM?]$^\1_\ ?=G_ /'Z/^%B:U_T3[Q'_P!]V?\
M\?K>T[QOH>K>)]7\.VFH1SZUI*0O?6:AM\"RKNC)XQ\P&>#6S+-'#$\DC+'&
M@+,SG  '4DGI1S1[![*M_P _7]R.(_X6)K7_ $3[Q'_WW9__ !^C_A8FM?\
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MX?TZ?4-3O+?3[&W7?-<W,@CCC7U9CP!3=+US3M:2=K"]M[U8)3!*T$@<1R
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M>?\ 75 1771#_B6V'_7'^IJ9278]?+X3?/:?1=%W.9_X2S5/^A.UO_ONU_\
MCU'_  EFJ?\ 0G:W_P!_+7_X]738HQ4<R['H^SJ?S_@CF?\ A+-4_P"A.UO_
M +^6O_QZC_A+-4_Z$[6_^_EK_P#'JZ;%&*.9=A\E3^?\$<S_ ,)9JG_0G:W_
M -_+7_X]1_PEFJ?]"=K?_?RU_P#CU=-BC%',NP>SJ?S_ ((YG_A+-4_Z$[6_
M^_EK_P#'J[?1/'^LP:7;H/ /B&0!?O+)9X/_ )'K.Q7I'AL#^Q;7_=J92C;8
M^CR.G4=:=JG3LNYR_P#PL36O^B?>(_\ ONS_ /C]'_"Q-:_Z)]XC_P"^[/\
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MD*N<CCD9 /DWX8_%+Q!K_P 9=7^)?Q&^$_Q-N?$JF73_  MHZ>&W:PT.R/\
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M/8__ "/7%>'?CCJ7A"U\0GX@ZYX3UR#37@2#4/!KLTL\TLAC6U:Q,LLB2[\
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M\OZ2#ZG2\_\ P*7^9Y__ ,*W\0_]%*\1_P#@/8__ "/1_P *W\0_]%*\1_\
M@/8__(]>@44<\OZ2#ZG2\_\ P*7^9Y__ ,*W\0_]%*\1_P#@/8__ "/1_P *
MW\0_]%*\1_\ @/8__(]>@44<\OZ2#ZG2\_\ P*7^9Y__ ,*W\0_]%*\1_P#@
M/8__ "/1_P *W\0_]%*\1_\ @/8__(]>@44<\OZ2#ZG2\_\ P*7^9Y__ ,*W
M\0_]%*\1_P#@/8__ "/1_P *W\0_]%*\1_\ @/8__(]>@44<\OZ2#ZG2\_\
MP*7^9Y__ ,*W\0_]%*\1_P#@/8__ "/1_P *W\0_]%*\1_\ @/8__(]>@44<
M\OZ2#ZG2\_\ P*7^9Y__ ,*W\0_]%*\1_P#@/8__ "/1_P *W\0_]%*\1_\
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M9_Z[W_\ Z.6A29U4U^XK_P"%?^EQ,G^Q+W_H/ZA_WQ#_ /$4O]B7G_0?O_\
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M\&^'_$FEZ4\FKP:%XBM&TFXNK<6:7DDT1MY")/\ 2"A0-N(5&R08^ :V;?\
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M(\ZYG64*5SAC\@!;/.<U])01^3"B9SM4#/T%?%6L?M%>/_%>G:QH<GV&VU*
M:'JEAJ/]G7VC1-Y]]'&8F260RR0_]-<)O!8;!7LO@SX]:S!KOB;PMXHT>ZU?
M7=$U&*R.H>%M'N)K2198A)&[IN=H<9(;<Q'0@\X ![I17RSXE_:P\3:3H'B!
M+70=,?Q#X9LM3N=:BF,PAB:"14M57'.)A)&_4D*&]*-5^.GQ2\*W>I_VU#X3
MOK'2=3TNTN?L%M=0R7,=\VW"%I6\MHLYW'=OXX3F@#ZEHSSBOC*P_:K\1^"?
M!$=M9^'K.YO[IY9]'M[FYN[@SQ1ZA<1WI>1V>1C&B"0#H =O0 5Z%8_%;5_&
M%SX+\=6#+#H-_P")'T>TBB,FV^TZ4"-9F7>5+"4%@V.%7'<T ?1E%(IR*6@
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MY,9N0/:4Q1E_[Q4$\U9_X0_5OL%O!_PF.KF6.(1M<^5;;Y&V.N\CRL9RRMP
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MCF.WRO!''[O'<'\!2OX4U-HE7_A+-55@V[>([?)&2<?ZOI@@>O HLNXN>?\
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MQF)4MM.32M-L(+=8HK&W!W,%QU+''I@#%=Q110 4444 %%%% !1110 4444
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MC#;WR01K+IUQ9S3SV]S%ZNLLRL >,QCU-4/&'[&FG>(].TC38->":99>'O[
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MK6UI/[(GBQM:_M+6?%6EZE=Q6%]8+<7L%U?_ &L3G(>6*>8QQ@#@QQ*!W!%
M'IVJ_M/^%+:Z\.1:?'J.I?VOJ\6D,#IUU;R6KNA=7>.2(-M*C(XYSP:L6_[1
MOA+6O$&G6^CZ]I4^F/\ :_M=S=&Y@/[A-SF F'RY O.\[P%QW/%><>&/V6_%
MNB1:7*WB6QB73=:M=2L]%62\N;&UCBC9)$A:>1I(]^[=M'R*1@#O6SK'[*LV
MM^%?"^A3Z[##!I5EJ=I-)#;',GVH?*R@G VG!(.<^U 'JO@+XP>$OB9<W=MX
M=U;[;<VL:32P2VTUO)Y;_<D5944M&W9URI[&OC?_ (*0_P#([>$?^O"3_P!#
M-?6?PH\)>-_#C,OBO6=&O;6VLX;&RM=(L7BPL8QYLDDC%BS #Y!\J]LU\F?\
M%(?^1V\(_P#7A)_Z&:N&Y\YQ#_R+Y_+\SX\HHHKH/QT**** "BBB@ KW'P3_
M ,D;TG_L+WG_ *#'7AU>X^"?^2-Z3_V%[S_T&.FMS#$_[I6_P_JAU%%%:'P
M4444 %%%% !7LGAS_DF'AG_KO?\ _HY:\;KV3PY_R3#PS_UWO_\ T<M-'72_
M@5_\*_\ 2XBT4451\^%%%% !1110 5ZKH/\ R*.B_P#7.7_T:U>55ZKH/_(H
MZ+_USE_]&M4RV/K.'OXM7_#_ .W(LT445B?7!7J_PN_Y%R3_ *[M_(5Y17J_
MPN_Y%R3_ *[M_(5G/8^NX8_WY_X7^AV-%%%8'ZP%%%% !1110 4444 %%%%
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M&_!/I7>U@^!_"%IX#\+:?H5C)++:62%(WG(+D%BW)  ZDUO4 %%%% !1110
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M@]?^?"?_ .2*/^%Z>-.>=!_\ )__ )(HHH]G#L'UW$_\_']X'XZ>-.>=!_\
M "?_ .2*#\=/&G/.@_\ @!/_ /)%%%'LX=@^NXG_ )^/[P_X7IXT]=!Z?\^$
M_P#\D4?\+T\:>N@]/^?"?_Y(HHH]G#L'UW$_\_']X?\ "]/&GKH/3_GPG_\
MDBO:? FLWGB#PO8:A?\ D?:YE)?[-&R)U(X#,Q'YFBBN>M&,4K(]G*L16JUF
MJDFU;_(I?$WQ+J/A7PRU]IGV7[4)40?:XFD3!//"NIS^->1_\+S\:#_H _\
M@OG_ /DBBBJHPC*-VB<SQ-:E7Y83:5D'_"]/&GKH/7_GPG_^2*/^%Z>-/70>
MO_/A/_\ )%%%;>SAV/(^NXG_ )^/[P/QT\:>N@_^ $__ ,D4?\+T\:>N@]?^
M?"?_ .2***/9P[!]=Q/_ #\?W@?CIXT]=!_\ )__ )(H/QT\:<\Z#_X 3_\
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M_P#)%%%'LX=@^NXG_GX_O#_A>GC3(YT'_P  )_\ Y(H_X7IXTXYT'_P G_\
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M_ "?_P"2*/\ A>GC3UT'K_SX3_\ R1111[.'8/KN)_Y^/[P_X7IXT]=!Z_\
M/A/_ /)%!^.GC3UT'_P G_\ DBBBCV<.P?7<3_S\?W@?CIXTYYT'_P  )_\
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1%%%%1*G#L=E#%XB2=YL__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tmb-20220511xex99d1013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  Y &D# 2(  A$! Q$!_\0
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MR)R<"08_O1L/YBJG]OV((S,!D;L@9&/PIL?B;29655O[?<W0%P,T6?8#1\Y
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MLYYEMY I)^H-6_L=Q'S9:EG'_+.Y E7\QAOU-&E^&M.TVV:.*T4^:WF2-/\
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M*_1!U_X%FMBBDM $5510J@* ,  =*6BB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tmb-20220511xex99d1007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $I Z@# 2(  A$! Q$!_\0
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MGCN^O-%\1:GI>H>+_#5YXEB\*3-:W6M:=#HD,-V+-ED1RHNU7<J.K%5.#P:
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MPJ%#1%%AMU=3&P<XR:^Y: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;1Z"@J#V%+10 FT'L*,#T%+10 FT>@HVCT%+10 @ '08I:** "BBB@ HHHH
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M7V@+XRTZW\:6%S:6\%V;@1WMA 7(+6\*S6A4)M W.<=<>K:U\=OB/HWC.W\
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MIKP)_P!"IH__ ("I0?@WX$49/A31P!US:I1:/F%\3VC][_R.O^U0_P#/6/\
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MZTS[)#_SS7]:=;B_"T9<KI2V3W757(P_AYF>(@YJM!:M?:Z-KMY'ZB_:HO\
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M_6C_ %SPO_/J7WH/^(:YI_S_ *?_ )-_D?J(;J+/^L3_ +Z%+]JB_P">B?\
M?0KX(^%GAS2]1\)Z]+=:?;W$L5]:HCR)N908YB0#Z' _*NC_ .$0T7_H%6G_
M 'Z%>S3XAP]2G&HH/57Z=[?H?-5N$,PHUIT74A[KM]KLGV\S[4^U1?\ /1/^
M^A1]JB_YZ)_WT*^*_P#A$-%_Z!5I_P!^A1_PB&B_] JT_P"_0J_[?H?R/\#/
M_5/,/^?D/Q_R/I_5?A!\/M<\3OXCO_"FAW>O/)'*^I2VL;7#/& (V+]25  '
MIBNT%S$/^6B?]]"OBS_A$-%_Z!5I_P!^A1_PB&B_] JT_P"_0H_M^A_(_P
M_P!4\P_Y^0_'_(^U/M47_/1/^^A1]JBZ^8G_ 'T*^*_^$0T7_H%6G_?H4G_"
M(:)_T"K3_OT*/[?H?R/\ _U3S#_GY#\?\C[4^U1?\]$_[Z%+]JA_YZI_WV*^
M3?!W@?P]<C5?.T2QEV6ZLN^$'!\Q1D?A6L/ 'AK_ * .G_\ ?@5V0S:C."GR
MO7T/-GD&.A4E3YH:>O:_8^G/M4/_ #U3_OL4?:H?^>J?]]BOF/\ X0#PU_T
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M#SK#]E5ED9R5(WY9FK[<VCTHP!0 V(DHI/7'-/I,8I: "BBB@ HHHH ****
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MQGXB(/((EMN?_(-%H]P]K6_Y]_BCLLT9KCO^$ O/^AR\1_\ ?RW_ /C-'_"
M7G_0Y>(_^_EO_P#&:+1[A[6M_P ^_P 4=CFC-<=_P@%Y_P!#EXC_ ._EO_\
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MZBD $A<IL,GIO*?(7QN*_+G'% '7#H**!TI: $I&[?6G4UN@^HI ?AU\9O\
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MR-EC_P #_P#0&KV.OJ,K_@OU_P CX3//]Y7HOS8E%+17L'SHE%+10 E%+10
ME%+10 E%+10 E%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/X#_ ,<__2Y!1117 >J%%%% !1110!ZU\'_^1.\1?]A"S_\ 1<]=37+?!_\
MY$[Q%_V$+/\ ]%SUU-?<8;_=J7I^K/RS&_[]B/\ %_[;$****Z#E"BBB@ HH
MHH$=-X(_YC'_ %[)_P"C5K:'2L7P1_S&/^O9/_1JUM#I7MT?X,/G^9\QB/\
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M ./T<J[A]8E_S[E^'^9U]%<>-(\:-T\3:5_X*&_^/TO]C>-?^AFTO_P4/_\
M'Z.5=P^L2_Y]R_#_ #.OHKD/[&\:_P#0S:7_ ."A_P#X_1_8OC7_ *&;2_\
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M *&;2_\ P4/_ /'Z.5=P^L2_Y]R_#_,Z^D;M]17(_P!B^-?^AFTO_P %#_\
MQ^D_L;QJ",^)=+QD?\PAO_C]'*NZ#ZQ+_GW+\/\ ,_&GXRG/Q?\ '/\ V'K_
M /\ 2B2N.KM_BVUO'\5?&BW$+S7"ZW>B22.38KMY[Y(7!P">V3CU-<GYUC_S
MZ3?]_P ?_$U^55J,?:2]];OO_D?OF%QU14*:^KSV7\O;_$5,48JWYUC_ ,^D
MW_?\?_$T>=8_\^DW_?\ '_Q-8^QC_P _%^/^1T_7ZO\ T#S_ /)?_DBIBC%6
M_.L?^?2;_O\ C_XFCSK'_GTF_P"_X_\ B:/8Q_Y^+\?\@^OU?^@>?_DO_P D
M5,4JCYA]:M>=8_\ /I-_W_'_ ,32K-8[A_HDW_?\?_$T>QC_ ,_%^/\ D'U^
MK_T#S_\ )?\ Y(]R\5?\BC\,O^Q2M?\ T?<US-=+XG!'A7X<ER&1O"UJ8E48
M*)Y]QA2>=QSGYN.O3CGF_D_NM_WU7@YAAX/%3?M8[^?^1]5D^858X"DOJTWO
M_+W?]X2BE^3^ZW_?5'R?W6_[ZKS_ *M#_G['\?\ (]G^TJO_ $"U/_)?_DA*
M*7Y/[I_[ZH^3T;_OJCZM#_G['\?\@_M*K_T"U/\ R7_Y(2BE^3^ZW_?5'R?W
M6_[ZH^K0_P"?L?Q_R#^TJO\ T"U/_)?_ )(]=T/_ ))AX7_Z^M1_]#BJ/-,T
M:.X/PV\-LL\:PFYO]B&++*=\6<MGG/'88]ZB\NY_Y[Q_]^__ *]5C,-!U5^]
MCM'O_*O(RR[,JJHM?5:GQ3_E_GE_>+&:,U7\NY_Y[Q_]^_\ Z]'EW/\ SWC_
M ._?_P!>N'ZM#_G['\?\CU/[3K?] E3_ ,E_^2+&:,U7\NY_Y[Q_]^__ *]'
MEW/_ #WC_P"_?_UZ/JT/^?L?Q_R#^TZW_0)4_P#)?_DBQFBJ_EW/_/>/_OW_
M /7H\JY_Y[I_W[_^O1]6A_S]C^/^0?VG6_Z!*G_DO_R1[%\'S_Q1WB+_ +"%
MG_Z+GKJ<UPOPIMM3D\(Z^;>^MX4%_:;E>U+DGRYL$'>,=^,'.:Z3[%K/_02M
M?_ (_P#QROM<-0BL-27M%MY]WY'YCC,?4>-KOZO/XO[O\L?[QK9HS63]BUG_
M *"5K_X!'_XY1]BUG_H)6O\ X!'_ ..5O[&/_/Q?C_D<WU^I_P! \_\ R7_Y
M(ULT9K)^Q:S_ -!*U_\  (__ !RC[%K/_02M?_ (_P#QRCV,?^?B_'_(/K]3
M_H'G_P"2_P#R1K9HK)^Q:S_T$K7_ , C_P#'*/L>LC_F)6O_ (!'_P".4>QC
M_P _%^/^0?7JG_0//_R7_P"2.\\$=-8_Z]D_]&K6T.E<9X-LM>8:MY>K6:?Z
M,F[=8%LCS5Z?O1BM;^S_ !#_ -!FR_\ !<?_ ([7LT:4?8Q]]=>_?T/F<1C:
MGUBH_83Z?R]E_>-VBL+^S_$/_09LO_!<?_CM']G^(?\ H,V7_@N/_P =K7V2
M_G7X_P"1E]=J?\^)_P#DO_R1WO@+_D;+'_@?_H#5[%7SYX*TWQ,_B:S$.N6$
M<IWX9M-9@/D/;S17JG]B^-?^AETO_P %#_\ Q^OILM@E1=I+?_(^)SK%3EB4
MW2DM%V[OS.OHKD/[%\:_]#-I?_@H?_X_1_8OC7_H9M+_ /!0_P#\?KU>5=SP
M/K$O^?<OP_S.OHKD/[%\;?\ 0S:7_P""A_\ X_1_8OC7_H9M+_\ !0__ ,?H
MY5W#ZQ+_ )]R_#_,Z^BN0_L7QK_T,VE_^"A__C]']B^-?^AFTO\ \%#_ /Q^
MCE7</K$O^?<OP_S.OHKD/[%\:_\ 0RZ7_P""A_\ X_1_8OC7_H9M+_\ !0__
M ,?HY5W#ZQ+_ )]R_#_,Z^BN0_L7QK_T,VE_^"A__C]']B^-?^AFTO\ \%#_
M /Q^CE7</K$O^?<OP_S.OS17)1:/XS6:,R>(],>,,"RKI+ D9Y&?/XXHI<OF
M5&M)_8:^[_,ZQ^@^HK\J-:_:E^+6G^&/B#X4'BS4E\1:_J5]JOAK5/*0R6&G
MZ?=:F+Y4PN"B)IT"X;G$[D9VBOU8(R*\UN/V;_AI=FW:;P;IDCV\.HVT3,C$
MI'?ES>*#G.)3+)G_ 'VQC)J3J/E71OVMO&GACQKJNF6E@WBC4M1U?P7X?MH-
M8U3R;6&74M&DGDF01P%HQYB!G&7W98C;@*=_2OVV/&=U$J>)?#NA>$K*[M_$
M]@NLVVHS7WV.^T>.1YKAXO)7=;G:-H!+D@\ 8S]'I^SO\.8]8355\):>NH)>
MZ?J*W&&W"XL8&@LY/O=8HF9%]CSFK,/P'\ 07%I,OA73V>TN-0NH=Z%PLE\"
M+QL$D'S0Q# \$'H* /GO]@SXA>//$]_K^F^/-8UFYN7T'1=;M+/7F@EG9;F.
M;S;J*2!%58)'C(6%LNFP[L9%?85<%\+_ (%^!/@P+_\ X0OPS9Z ;\1BY>WW
M,TBQ@B--SL2%7<VU0<#)P*[V@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** $/0U\N>/I?$#^'?CEXPM/'.N:)J7A*_N9-+BBN(S9(EOIUM<+$\#
MH5='=G#9(;#G!!QCZCKSW6_@#X#\2:W=ZKJGAZ&_N;RZCO;J*>>9K>>>,($D
MD@+^4S 1Q\E#]P>E '$Z)^T7J5_HS7=WH,5C<)XBTC0Y+5YVWQB[L;.YE)!7
M.^,W3KM[^6,XSQYQXW_:=\6ZC\&SK7]GV^B1>,O".H:_X9NM*NGDO+3R8TE1
M)P\817:&56# [5<%#G*L?H>_^"?@K4_&'_"4W/A^WEUPW4-^;DO)@W,2A(IS
M&&V&544*)-N[:-N<<51MOV=_AW:1:Q#%X7M%@U6UGL;F'S)3&+>9_,FBC0MB
M%'<!F6,*"0#V% 'A>G?%[Q7\,?'>M://IWB+SKW2K!M%T#QAJ-O.US=RZC'9
MM,EU!Y@BA0W5N) [%CN4HHP=W60?M&>*[WXA2_#&'1-'_P"$\MM2FMY;M[J8
M:8ULEE#=B4,(S('(N(HS&1P=[ L!SZ1!^SO\/8H-8BE\-07IU>U2RO)K^>:Z
MFD@1_,2,22NSJJO\X"D88!AR :E7X">!4T>+35T%%ACOFU-9Q<SBZ^U,AC:8
MW&_S2YC.PDORORGCB@#Q+P+^TOXETGP%H-AK&GPZAXKUG1["?16N+O(U"]GO
MWM;B%G1=I$!:%RR9S&Q; Q7U<IW"O*(O@%IEO\0/ ^J6R:=8^&?!-I.FA:):
MV.U[6YF0Q22>:7(\L1,56,*.6R2<*!ZQ0 4444 %%%% ' ?M :Q?Z!\#_'FH
MZ5>2Z=J5KHEW+;7D !D@D$3;9%R"-RG!&>,BOG/5/VDO%G@CQEH>B>))'N/$
M?A+1]>EU_3;9DABUP0P6SV%ZA(^1)@S'/2-S*ISLKZ[U_0;#Q1HE]I&J6J7N
MFWT+6]S;2YVRQL,,IQV(-8?B7X5>$O&&M)JVM>'['4]073KC2?/N8]S&TG $
MT#=F1L<@Y[XQDT >32_M#^)?!WB^;0/&.CZ/;_V;<Z1)JFHZ;?.]O;V.H_:(
M(I?WBJ08[NW"/NPICD5P<Y08L7[5/BK6M#UW6M*\*Z<EIX=T"+Q5J-M?WLL4
M\UA<2W+VJP_N\"4VMJTK;\ /(B#/+#V"T^!'@6S\,:]X>'AZ"XTK7HA#J<5W
M++</=QA=JH\DCLY55X4;L+SC&:D\5_!#P/XVO;2ZUKP[:7DMM;+9J 7C1[=6
M#K!(B,%EB##(C<,HR>.30!P_[1'B+QA<:#\.)OAYJG]F:SJ6OQRQ0W486*_B
M6PN[G['/N!*)+Y2H6'*$AOX2#Y9\.OVG?$?CCXI^,+?P^OVY-5U+0]*TS2]:
MF\B+1)FTVZN;])@J[S(C6LBF,<F0#D+DCZTU3P]I^LW6F7%[:QW$^F7)O+-W
MZPS>6\>]??9+(OT8UR.J_ 7P%K-[K%[<^&;,7NKWL&HWEW 7@FDNH4:.*<.C
M*R2*C,NY2"0S DY- 'B\O[6?BO[7Y0\*Z7''HFCZSJWB20ZA(^P:9?/9SQV@
M6(^89&0,A?9@9W8(Q5^W^)WCZW\=O!XIALK))H/##P6>BZ@9(5-YJ4L4Q+-&
M&RH 0_PR*H(*\X]GT'X/>#?#)A_LWP[8VWDZ?+I2@(6#6LLOFRQL&)W!Y"78
MMDL222<FJ'AKX"^ _"(/]E>'8+<DV?S/++*P%K(9+507=B%B<DHHX7)P,4 >
M$:]^U-XANM&\16]_9)X;U*S:UOK?3[5+AM3:V75X;>0)&\02Z22)UQ);NZYD
MV_Q(Q]^^#'C^Z^*/@.U\3W%M;64.H2RO;6L$QDD@A5R@CGR!MG4JPD0?<8%<
MDJ3533?V??A_I%S)-:^&K=&;[BM-*Z0#[0EP5A1G*Q*9HHW*QA02BY!P*ZWP
M_P"$])\*OJ;:3816']I7DFH7:PY"R7#@>9)C. 6V@G&,G)/))(!L4444 %%%
M% !2-T_&EI",B@#Y G_:?\7_ /"G8;N/3M8&OOXSCT;^W6T@#3C;MXC%GMWY
MV_Z@^7NQG=[\UTW_  VYI8EURX7P]/<Z5:6VLSVDEK=I+<R'3HY9)//A"_Z.
MLH@E\IF8YPNX*74'UZ3X*>%9/ B>$#9S#0TU1=96(7#[Q<K?_;PV_.<?: &Q
MTQQTK#7]F;P:/[7@)U=M*U&&_A.D'59OL5N+T.+IHH@V%+^;)CKMWG;MS0!Q
MFE_M5ZQ-J-]#J?@";2[72YM)?4KEM5AD%M::BRK;RA0N7=6+>8@^Z%RK/G%$
MW[7,FG:3!JVH^"KRVT[6- OO$/AT)>Q23ZC!:JLC1R(.(9'BDCD0%F!!PQ5A
MBO4'^"OA62YU>=K*4R:JNFK=$SOAQ8/OM<#/&UNO][OFN&\2_LH>&[GP?XBT
MW1GNUO+W1[S1M,&IW\T]OI,%SCS8[9228E;:H^7D*JJ"% % &'XH_:#\90>*
M]"\-6_A1+'Q4FO6MM=Z-_:$4L5W9W.GWLL3BXV_NPLMJ^_"EAY)"APPSQVN?
MM8ZWKDD$FDP77A^]:QLVGL;@07$,$R^)TTF[4.!N<D+*%;A=I5L!J][T#X#^
M&-!U.#5"=1U+5H=2751J&I7\EQ.TR6\MM&"S'[B13R*$Z98MRQ).6O[+W@!+
MAYAIMR)&!!/VR3OJIU4]_P#G[)?Z?+TXH Y'QO\ M/R_#KP_->R:=;:B5N]>
M.=3U:WL"Z6-W+%Y$*[2TLC*GR@*  !O<$C/:_&#XTVGP_P#@+JGC^';$6TZ*
M73H[K"[KBX"K;(^,X!DE3=C. &/.*7Q#^SAX/\17;W$J:E9R3Q7UM=FQU"2#
M[7;W=P]Q/#(5.2AED=@ 01NP#CBNDO/A;H.HZ5X3TZZ@EN+3PQ<V]WI\<DS$
M>;!$T432?\]-H;<-W\2JW50: .(_9>^+C_%'P/J-O?Z[9>(M>\.:G-H^H:G8
M!5BO"N'AN45> LD,D;8' ;>!TKV6N>T[P+I&D^,=6\3VD#0:KJMK;VMXRR$1
MRK 9/*8I]W>!*R[L9("@\*,=#0 4444 %%%% !1110 4UN@^HIU-;H/J* /P
MZ^,W_)7_ !U_V'K_ /\ 2B2N.KL?C-_R5_QU_P!AZ_\ _2B2N.K\BK?Q9>K/
MZ&PO^[T_1?D@HHHK$Z@HHHH *5?O#ZTE*OWA]: /??%7_(H_#+_L4K7_ -'W
M-<S73>*O^11^&7_8I6O_ */N:YFOG\Q_WJ?K^A];DO\ R+Z7H_S84445YI[8
M4444 %%%% 'KVA_\DO\ "_\ U]:C_P"AQ5'4FA_\DO\ "_\ U]:C_P"AQ5'6
MF-_BK_#'_P!)1EEG\!_XY_\ I<@HHHK@/5"BBB@ HHHH ]:^#_\ R)WB+_L(
M6?\ Z+GKJ:Y;X/\ _(G>(O\ L(6?_HN>NIK[C#?[M2]/U9^68W_?L1_B_P#;
M8A11170<H4444 %%%% CIO!'_,8_Z]D_]&K6T.E8O@C_ )C'_7LG_HU:VATK
MVZ/\&'S_ #/F,1_O-3Y?D@HHHK4Q.@\!?\C98_\  _\ T!J]CKQSP%_R-EC_
M ,#_ /0&KV.OJ,K_ (#]?\CX3//]Y7HOS84445[!\Z%%%% !1110 4444 %%
M%% !1110!R__  M#P@/^9FTC_P #8_\ &C_A:'A#_H9](_\  V/_ !K7/A[2
M@,_V99\?].Z?X5XGX2_:8^&?C3QU'X/T_P /^($UX^4TMM>>#KVW%NDI81R3
M,\ $2,4;#.0/E//%7[OF<ML1W7W/_,]5_P"%H>$/^AFTC_P-C_QH_P"%H>$/
M^AFTC_P-C_QK*^(/C#P/\,?!6M>*]>CLX-&T=!)>RP6@F>(%E491%+9RZ\8S
MS72'3="6;RFL]/67"GRVBC#8)P.,=SQ1[OF'^T=U]S_S*'_"T/"'_0SZ1_X&
MQ_\ Q5'_  M#PA_T,^D?^!L?^-:*Z3HC%0+*P)9BJXB3DCJ!QU&#6!XR\3>!
M?A_X8O?$7B";2=,T:R=(KB[EC38CNXC5>!G<795 ZY(H]WS#_:.Z^Y_YE[_A
M:'A#_H9M(_\  V/_ !H_X6AX0_Z&;2/_  -C_P :OC3M!-PL M-/\]EWK'Y4
M>XKQSC&<<CFF&T\/*&)M]- 4!F.R/@$D GCN0?RH]WS#_:.Z^Y_YE/\ X6AX
M0_Z&;2/_  -C_P :/^%H>$/^AFTC_P #8_\ &M!],T*.XC@:ST]9I 2D9B0,
MV.N!C)ZBL+P3XA\'?$'3I;[1;>TN(([R[L6$EH(V\VVN'MY@%902!)$Z[NAQ
MQUH]WS#_ &CNON?^9=_X6AX0_P"AFTC_ ,#8_P#&C_A:'A#_ *&;2/\ P-C_
M ,:U_P#A'=+_ .@99_\ ?A/\*/\ A'=+_P"@99_]^$_PH]WS#_:.Z^Y_YF1_
MPM#PA_T,VD?^!L?^-'_"T/"'_0SZ1_X&Q_\ Q5:__".Z7_T#+/\ [\)_A1_P
MCNE_] RS_P"_"?X4>[YA_M'=?<_\S(_X6AX0_P"AGTC_ ,#8_P#&C_A:'A'_
M *&?2/\ P-C_ ,:U_P#A'=+_ .@99_\ ?A/\*#X=TL_\PVS_ ._"?X4>[YA;
M$=U]S_S)].U*UU:RBN[.XBNK64;HYH7#(P]01P:M5%!;16L2Q0QI%&O 1%
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M<"UTXP.0%E$<>TYZ8.,<T>[YA_M'=?<_\RC_ ,+0\(?]#/I'_@;'_P#%4?\
M"T/"'_0S:1_X&Q_XU'X3U'PKXT\.6FN:7:VDNG7*&2.22U6,[0Q7)5@".5/6
MML>'M*/_ ##+/_OPG^%'N^8?[1W7W/\ S,C_ (6AX0_Z&;2/_ V/_&C_ (6A
MX0_Z&;2/_ V/_&M?_A'=+_Z!EG_WX3_"C_A'=+_Z!EG_ -^$_P */=\P_P!H
M[K[G_F9'_"T/"'_0S:1_X&Q_XT?\+0\(?]#-I'_@;'_C6O\ \([I?_0,L_\
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M\P_VCNON?^9D?\+0\(?]#-I'_@;'_C1_PM#PA_T,VD?^!L?^-:__  CNE_\
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MX&Q_XU?L].T'4;2WNK6SL+BVN$$L4L<*,LB$9# @<@@@YJ8:%I)./[-L\_\
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M,IHP@H<ST]#S9Y_C9U)5.6.OKVMW/G?_ (2W0_\ H,Z?_P"!2?XT?\);H?\
MT&=/_P# I/\ &OHC_A'M,_Z!UI_WX3_"C_A'M,_Z!UI_WX3_  JO[*H_S/\
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M^-TDP0%R>V^#OCJ?XC_#G2-=O+7[%J$OFVU[;@$+'=03/!.%SSM\V)]I/;%
M':4444 %%%% !1110 4444 %%%% "'H:^9_&.C>.FL/C3X,TKP'J&H'QC<W)
MT_77O;6'3T2XT^WMMTA,OFC8R.2!&2=HQG-?3-)B@#Y/M?AMXY\,>)#X/LO#
M>H:CHZ>)]"U>'Q2UW"MN+*UL+.UD+(9/,\X26I8QA<%7W;CR*\_7]GOQO=>
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M\0Z/;&XCCOIHI-,*6ZW,@D\Q;6* YD5H@DDFY6=BH.5XWX:6'B[QE\/M+O\
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MQGC-3CX7Z0?^7O6?_!O<_P#Q=%H]_P  Y\1_S[7_ (%_]J=?N'K1N'K7(_\
M"K])_P"?O6?_  ;W/_Q='_"K])_Y^]9_\&]S_P#%T6CW_ .?$_\ /M?^!?\
MVIUVX>M&X>M<C_PJ_2?^?O6?_!O<_P#Q='_"K])_Y^]9_P#!O<__ !=%H]_P
M#GQ/_/M?^!?_ &IUV<]*6J>F:9%I-C#:0O,\40PK3RM*Y^K,23^)JW4'6KVU
M L!2;A6%K?@JPU^]^U7,^HQR; FVUOYH4P,_PHP&>>M9_P#PJ_2?^?O6?_!O
M<_\ Q=6E'JSFE.NFU&":]?\ @'7;AZT;AZUR/_"K])_Y^]9_\&]S_P#%T?\
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M'K7(_P#"K])_Y^]9_P#!O<__ !='_"K])_Y^]9_\&]S_ /%T6CW_  #GQ/\
MS[7_ (%_]J==N'K1N'K7(_\ "K])_P"?O6?_  ;W/_Q='_"K])_Y^]9_\&]S
M_P#%T6CW_ .?$_\ /M?^!?\ VIUVX>M&X>M<@?A?I _Y>]9_\&]S_P#%U3E\
M#^&H;.:[DU;4DMH6*23-KEP$0@[2"?,P"#Q]:+1[_@'/B?\ GVO_  +_ .U.
M[W#UHW#UK@]-\%>&=8A::PU?4;R)3AG@URX< ^Y$E1Z5X1\*ZZ\ZZ=K=_?-
MVR46^NSR>6WHV)#@_6BT>_X!SXC_ )]K_P "_P#M3T#</6C</6N1_P"%7Z3_
M ,_>L_\ @WN?_BZ/^%7Z3_S]ZS_X-[G_ .+HM'O^ <^)_P"?:_\  O\ [4Z[
M</6C</6N1_X5?I/_ #]ZS_X-[G_XNC_A5^D_\_>L_P#@WN?_ (NBT>_X!SXG
M_GVO_ O_ +4Z[</6C</6N1_X5?I/_/WK/_@WN?\ XNC_ (5?I/\ S]ZS_P"#
M>Y_^+HM'O^ <^)_Y]K_P+_[4Z[</6C</6N1_X5?I/_/WK/\ X-[G_P"+H_X5
M?I/_ #]ZS_X-[G_XNBT>_P" <^)_Y]K_ ,"_^U.MW4ZN4M?AOI=I=13I=:LS
MQ,'42:K<,I(.>07P1[&NKJ7;H;4W4:_>12]'?]$(32!@>]#+NKDW^&6DLS,;
MO6<DY.-7N1_[/3275A4E45O9Q3]7;]&=;N'K1N'K7&#X<:(S[!?:N6SC']L7
M.?\ T.I&^&&D*"3=ZR .O_$WN?\ XNG:/?\  QY\1_S[7_@7_P!J=?N'K1N'
MK7(#X8:0?^7O6?\ P;W/_P 72_\ "K])_P"?O6?_  ;W/_Q=%H]_P#GQ/_/M
M?^!?_:G7;AZT;AZUR/\ PJ_2/^?O6?\ P;W/_P 736^&.CHI+7>L@#O_ &O<
M_P#Q=%H]_P  Y\3_ ,^U_P"!?_:G8;AZT;AZUQY^&6CCK=ZR.W.L7/\ \73O
M^%7Z3_S]ZS_X-[G_ .+HM'O^ <^)_P"?:_\  O\ [4Z[</6C</6N._X5IHWF
M%/MNL;P,X_MBYS_Z'3_^%7Z3_P _>L_^#>Y_^+HM'O\ @'/B?^?:_P# O_M3
MKMP]:-P]:Y _#'2 ?^/O6?\ P;W/_P 72_\ "K])_P"?O6?_  ;W/_Q=%H]_
MP#GQ/_/M?^!?_:G7;AZT;AZUR/\ PJ_2?^?O6?\ P;W/_P 71_PJ_2?^?O6?
M_!O<_P#Q=%H]_P  Y\3_ ,^U_P"!?_:G7;AZT;AZUR/_  J_2?\ G[UG_P &
M]S_\71_PJ_2?^?O6?_!O<_\ Q=%H]_P#GQ/_ #[7_@7_ -J==N'K368<<]ZY
M/_A5^D_\_>L_^#>Y_P#BZ/\ A6.DJ0?M>L]?^@O<_P#Q=%H]_P  Y\3_ ,^U
M_P"!?_:GXS?&4_\ %W_'7_8>O_\ THDKCZ[?XMW;V7Q6\:6\:QLD6MWT:F6-
M78@7#@98C)/N>37*?VK-_P \[?\ [\)_A7Y56A0]I+WWN^G_  3][PM?'^PI
MVH1V7V_+_ 4Z2KG]J3?\\[?_ +\)_A1_:DW_ #S@_P"_"?X5CR4/YW]W_!.K
MV^8?\^(_^!__ &A4HJW_ &I-_P \[?\ [\)_A1_:DW_/.W_[\)_A1R4/YW]W
M_!#V^8?\^(_^!_\ VA4I5^\/K5K^U)O^>=O_ -^$_P *5=4FW#]W;_\ ?A/\
M*.2A_._N_P""'M\P_P"?$?\ P/\ ^T/<O%7_ "*/PR_[%*U_]'W-<QFNF\3J
M(_"OPY<9+3>%;65@QR 3/<#"@\*./NC Z^M<YYA]%_[Y%>#F$,-]:G>H]_Y?
M+U/JLFQ&9+ 4E'#Q:U_Y>>;_ +@S-&:?YA]%_P"^11YA]%_[Y%>=[/"_\_'_
M . __;'L_6,S_P"@>/\ X,_^T&9HS3_,/HO_ 'R*/,/HO_?(H]GA?^?C_P#
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MQFG_ $#1_P#!C_\ D"?-&14'V&/^]+_W\:C[%'_>E_[^-1[/"_\ /Q_^ _\
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MGQ/_ #[7_@7_ -J==N'K1N'K7(_\*OTG_G[UG_P;W/\ \71_PJ_2?^?O6?\
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M)!1116)U!1110 4J_>'UI*5?O#ZT >^^*O\ D4?AE_V*5K_Z/N:YFNF\5?\
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M.UO=:?!:QQ8*;?,5X2Q[8Q@YXJWX+^+NL_'O2OA&=+\77OAQM5L=7&MR:-'
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MP8EQU->CCI0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ/P-@U^U^"O@&'Q7]H_X2B+0+!-6-VVZ;[8+=!/O/=MX;)[G-=O110 4444
M%-;H/J*=36Z#ZB@#\.OC-_R5_P =?]AZ_P#_ $HDKCJ['XS?\E?\=?\ 8>O_
M /THDKCJ_(JW\67JS^AL+_N]/T7Y(****Q.H**** "E7[P^M)2K]X?6@#WWQ
M5_R*/PR_[%*U_P#1]S7,UTWBK_D4?AE_V*5K_P"C[FN9KY_,?]ZGZ_H?6Y+_
M ,B^EZ/\V%%%%>:>V%%%% !1110!Z]H?_)+_  O_ -?6H_\ H<51U)H?_)+_
M  O_ -?6H_\ H<51UIC?XJ_PQ_\ 24999_ ?^.?_ *7(****X#U0HHHH ***
M* /6O@__ ,B=XB_["%G_ .BYZZFN6^#_ /R)WB+_ +"%G_Z+GKJ:^XPW^[4O
M3]6?EF-_W[$?XO\ VV(4445T'(>B_ K_ )'.7_KT?_T):]^KP'X%?\CG+_UZ
M/_Z$M>_5^AY+_N:]6?CW$O\ R,9>B_(****]T^6"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** ,UO$.ED8_M&U_[_+_ (UYEX#^&'ACP9K?
MVUM0LKF/3M0U.[T-5F"_88]0D6:Z0J#M8^=YFU\9".5[G/6M\'O N<GP?HG/
MK81?X5Y;X?\ 'W[-_BGQF?">F77@FZ\1_:I+(::L4(F:="0\84CEAM;@<\&M
M/<\SAOBNT?O?^1TFO?!;X=Z[K5SJXO;G2M2N+Z749+G2=:EM',TL,,,IS&XP
M'6WBW*."5W=229;SX-?#.X\(6WAZ!(]/MK2ZEO[6\LM3DBOK>ZEW^9<+<A_-
M\QO,;<Q8[@<'(XKCO#?Q._9G\6^)(M TF_\  ]YK,LK016210B261<Y1 1\S
M?*>!SQ71VMS\#;SPGH'B:&S\*2:'KUY%I^F7BVL6R[N9)#&D4?RY9RZL,=?E
M/I1:'F%\7_+'[W_D:NF?"GX>:9\.M9\%^8MWI.MI(NJRWFHM-=7[R($>2:=F
M+LY55&<\!0!@ "NXU*\\/ZQI=UIM]<6-W874+V\]O-(C)+&RE61@3R""01[U
MYS\1(O@C\);6RN/&-IX0\-P7LIAMWU&""(2L!DA<CG Y)Z =:T-2\-?"/2->
MT#1;O1O"\&JZ^95TNS:UA\R\\N(RR&-<?,%0%B>F*+0\POB^T?O?^1B:7^S]
M\+M+T?5=.WRWD=_%!;+/>ZQ+-/:002"6VAMY6?="D4@#IM.0P!).!72Z+X \
M#Z'X U#P?%<K<:5J4<R:A)=Z@9KF]:5=LLDLS-N9V'4YXP ,  #FM&U'X#>(
M?'EWX+TV/P=>^*[226*?2(886N(WC_UBLF,@KW]*[L?!SP+_ -"=H?\ X 1_
MX4>YYA?%]H_>_P#(SYM&T^^^*EIXMN];LI8-.TF33M/L@ZYBDFE5[B9FSU*P
MP(H'0!\YW<=C_P )%I?_ $$;7_O\O^-<]_PISP+_ -"=H?\ X 1__$T?\*<\
M"_\ 0G:'_P" $?\ \31[GF%\5VC][_R.A_X2+2_^@C:_]_E_QH_X2+2_^@C:
M_P#?Y?\ &N>_X4YX%_Z$[0__   C_P#B:/\ A3G@7_H3M#_\ (__ (FCW/,+
MXOM'[W_D=#_PD6E_]!&U_P"_R_XT?\)%I?\ T$;7_O\ +_C7/?\ "G/ O_0G
M:'_X 1__ !-'_"G/ O\ T)VA_P#@!'_\31[GF%\5VC][_P CH?\ A(M+_P"@
MC:_]_E_QH_X2+2_^@C:_]_E_QKGO^%.>!?\ H3M#_P# "/\ ^)I?^%.>!1_S
M)^A_^ $?_P 31[GF'-BNT?O?^1UL%Q%=1++#(LL;<JZ'(/XU)5/2])L]%L(;
M'3[2&RLX1MCM[= B(/15' [U;K,[5>VNY4NM7L;*7R[B[@@DQG;)(%./H347
M_"1:7_T$;7_O\O\ C6?KOP]\,>)[X7FK^'],U.[""/S[NU21]HR0,D9P,G\Z
MSO\ A3G@7_H3]#_\ (_\*T7)UN<DGB>9\JC;U?\ D=#_ ,)%I?\ T$;7_O\
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M7_H3M#_\ (__ (FCW/,.;%=H_>_\CH?^$BTO_H(VO_?Y?\:/^$BTO_H(VO\
MW^7_ !KCO$/P[^&OA30=1UK5O#/A^QTO3[=[JZN9;&,)%$BEF8G;T !-<WX'
M/P3^)%[/9>'=-\,ZC?01">2T6QC698\[=^QE!VYXW8QFCW/,+XOM'[W_ )'J
MO_"1:7_T$;7_ +_+_C1_PD6E_P#01M?^_P O^-<Z/@_X#/\ S*&A?^ $7^%+
M_P *=\"?]"?H?_@!%_\ $T>YYA?%]H_>_P#(Z'_A(M+_ .@C:_\ ?Y?\:/\
MA(M+_P"@C:_]_E_QKG?^%/> \9_X1#0L>OV"+_"L36?"GPG\/W$]O?:%X:@N
M8(HKB6W-G$94CDE\J-R@&=K2?*#C&0?0T>YYA?%]H_>_\CO?^$BTO_H(VO\
MW^7_ !H_X2+2_P#H(VO_ '^7_&N=_P"%/> R<?\ "(:%G_KPB_PI1\'? AZ>
M#]#_ / "+_XFCW/,+XOM'[W_ )'0_P#"1:7_ -!&U_[_ "_XT?\ "1:7_P!!
M&U_[_+_C7CUEK/P&U#Q?)X7AMO"IUQ+Q].^RO9QJ6N4)#0J2N&<%6^4'/!]*
MZ_0OAY\-O$NEPZCIWA?0;FSF+*DJZ?& 2K%&ZKV92/PHM#S"^+[1^]_Y'9?\
M)%I?_01M?^_R_P"-'_"1:7_T$;7_ +_+_C7/?\*<\"_]"?H?_@!'_P#$T?\
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MUSW_  ISP+_T)VA_^ $?_P 31_PISP+_ -"=H?\ X 1__$T>YYA?%=H_>_\
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M_ "/_P")H_X4YX%_Z$[0_P#P C_^)KV_<\SYF^*[1^]_Y'0_\)%I?_01M?\
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M\)%I?_01M?\ O\O^-<]_PISP+_T)VA_^ $?_ ,31_P *<\"_]"=H?_@!'_\
M$T>YYA?%=H_>_P#(Z'_A(M+_ .@C:_\ ?Y?\:/\ A(M+_P"@C:_]_E_QKGO^
M%.>!?^A.T/\ \ (__B:/^%.>!?\ H3M#_P# "/\ ^)H]SS"^+[1^]_Y'0_\
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MTO1_FPHHHKS3VPHHHH **** /7M#_P"28>%_^OK4?_0XJCQ4FA_\DO\ "_\
MU]:C_P"AQ5'6F-_BK_#'_P!)1EEG\!_XY_\ I<@Q1BBBN ]4,48HHH ,48HH
MH ]:^#__ ")WB+_L(6?_ *+GKJ:Y;X/_ /(G>(O^PA9_^BYZZFON,-_NU+T_
M5GY9C?\ ?L1_B_\ ;8A11170<AZ+\"O^1SF_Z]'_ /0EKWW%>!? K_D<Y?\
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M."*[L<"I:2V9T4YSFGSQY?N_0"<4;AZTC#/?%>?O\*]0=V8>/_%"@DG:)+;
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M ,"A_P#)$=%2>:/^>:?K_C1YH_YYI^O^-'L*'_/Y?=+_ "%]=QW_ $"2_P#
MH?\ R1'14GFC_GFGZ_XT>:/^>:?K_C3]A0_Y_+[I?Y!]=QW_ $!R_P# H?\
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MO\'O UWJ7BB:)/%FNV3?97;S+=X0Q^9>.8CQ7LW_  JC4?\ HH/BG_OY;?\
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M,?4X$2**]:SC,T:(<HJOMW *0" #QVH ^*O#W[1'B[X1_!#2]0T[4=+\<?\
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MX7_Z^M1_]#BJ.M,;_%7^&/\ Z2C++/X#_P <_P#TN04445P'JA1110 4444
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M?#W_ $&K#_P)3_&OCZBNGZJNYXW]OU/^?:^\^P?^$Y\/?]!JP_\  E/\:/\
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MO^@U8?\ @2G^-?'U%'U5=P_M^I_S[7WGV#_PG/A[_H-6'_@2G^-'_"<^'O\
MH-6'_@2G^-?'U%'U5=P_M^I_S[7WGV#_ ,)SX>_Z#5A_X$I_C1_PG/A[_H-6
M'_@2G^-?'U%'U5=P_M^I_P ^U]Y]@_\ "<^'O^@U8?\ @2G^-'_"<^'O^@U8
M?^!*?XU\?44?55W#^WZG_/M?>?8/_"<^'O\ H-6'_@2G^-'_  G/A[_H-6'_
M ($I_C7Q]11]57</[?J?\^U]Y]A)XWT"1U1=9L6=B%51<)DD]!UHKY)T;_D,
76'_7S%_Z&M%9RH*/4[</F\ZR;<$C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tmb-20220511xex99d1017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  R '0# 2(  A$! Q$!_\0
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M>7MMBS-,(DQG<ICPHZM(!ZU[@>E>$?"[PFWC2+Q'JC:A=6:?\)!J5GNBP3/
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H)))/4DT45:^%D?:1IT445!84444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tmb-20220511xex99d1014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H (H# 2(  A$! Q$!_\0
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M/:SH$T5S<S-EHK2ZA*RQRD'EX6P&&>2K$<,#CG8/B)H'B'4+?[3X/:;Q5-&
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E&.()\D=Y"568@XP#)&\;$>L1/5C7HIHHK2?1D1ZCJ***S+/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tmb-20220511xex99d1011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !! (4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]38EP!SGC
MKGO3PN>N1^-*OW1]!3J2V ;Y8]Z/+'O3J0G%,!OECW_.@I[?K7FWQ3\>ZC9S
M6WA/PI!+=^*=5<0"Y108=+B(R]Q*3QE5Y5!DEF3("G-=-J6JQ> O"\ DDN-2
MGC5+:WCDD9Y[R<C"KDDDLQ!)/. ">@I7'8Z/90$'^34-D\TEM$]Q&(IV4%T!
MR%/<9[X]:AUC5;;0],N;^\D\JVMT+NWT[ =R>@'<D 4Q$=SJ\5OK%GINQI)[
MA7DRI'[M5'5N>A/'UK0V5Q_@30KP37GB+6)I)=4U3#1P2QA?L5OU2!>,_P"T
MV>K'H,5UD]Q':QM)*ZQ1KRSNVU1]2:2 DV<TOEBN:F^(N@1W!@@NY=2E#;6&
MEVDUZ$;T8PHX7\<4Z#QQ:WK.EIINM7$B]5DTJXMP?HTRHI_.G<#H]@]_SI-O
MH#^=8*^*+PX_XIG6,>_V?_X]4H\1SG .AZHI/JD?'_C]*Z UU!#<ICWS3\#_
M ":IV=_+=/AK"YMEQ]^;8!],!B?TJ]3 ;A?\FBH;C.X?XT5.O8=B9/NCZ"G4
MU<!1VX'6N8USQ[9:5=S6%I#-JVIPIYDUM:8VVZ_WII6(CB&/FPS;B 2JMC%/
M9".H->:?$WXKZ=X:+Z9#K-IIMX2%GNY?WCP _P#+.&$ M<7+#A(D5CR"P^ZK
MX\^@^,OBPT'VOQ-=^&?#OF&24>&Y! UV@(*QQW#Q^<4/(,R>26'W%P0];O@?
MX=6WACQ+J?V3P]8:%HMJZBP^R,&EOY&13+=3G&XR;B4&\LV%+;OGP)=V/1;G
M-V/C?3/ /AK4O$S^&-:&G01--+J=Y +3:I.<.MT\=P79L9;RSN9AC( Q;\,V
M7B7XB/'XAN@^@M=(/L\CDM)8P$#*6\<B+\S]6FD4-V5<!2/7]HKDOB1?RQZ'
M'I=HX6^UB9;"(YP55L^8W'(P@;![$K1:P7*'P:TRWL_!RWUO-=S?VI/+?,;V
M>2:52S'Y2[G<0,<9JSKB-XM\5V^C@AM-TPK=WZ$9$LA&88SV(_B(.0>.XKI]
M,T^'2;"VLK91'!!&L:* !@ 8K"UKX:^'O$&J37]]:W#SSJJSK%?3Q13!1A?,
MB1PCD#C+*3CBG;0#0U_Q?H7A.%)=<UK3]&B?A9-0NXX%;Z%R,UR.L?$;P1XF
MMDM9K.[\56GF++$]CH-WJ%L74Y5UECA:,$'HVX8]:Z7P_P##SPOX3D>71?#>
MDZ1+)R\EE91Q.Y]690"3]:Z+&11N!Y6;B:[+20^ O'*Q@_N_+UN&V1AZA/MZ
ME1[%0?:I#I?BZY93;^&88;8]K_QM?1S@>ZQPR+GZ.:]0P*6BP7/*W\-^,EGS
M%I.G[.@\SQKJA_3R<5H6^F>-(5_Y!>D$XZ/XDOG'ZPUZ)13L%SS:ZTOQO<D*
MVD:.J YS%XHU"(_DL J.6T^(L<</V?1M%5PS%S_PE=W@#. ?GL9-W!R00!D
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tmb-20220511xex99d1016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  N +T# 2(  A$! Q$!_\0
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M59A?3[.O^%<3G2;O9C.6\&^-=#MS?:>FJV26=OLFM2]RG^I==RCKT'(K?'Q
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2 4444 %%%% "8Q1C-+12 __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tmb-20220511xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  \ ,H# 2(  A$! Q$!_\0
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M;')RHZ9S\[_L\ZYXCL?C+X7CT*[NS<7=]''<PK(S)- 3F7S!T(";CD]" >M
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4I5JU,PQ5N:I9)+5**\W:[?4__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tmb-20220511xex99d1015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20220511xex99d1015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  J ,P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**0G%
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M ,O)?B3%2LTM"#P9X\N/$6M7NC3Z<4NM,MH'O;R$_P"C+<2#<85R=VY1@D$
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J@HHHH 3 I:** $P*6BB@!*6BB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
